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ABSTRACT 
 
 CHARACTERIZATION OF 50S RIBOSOMAL SUBUNIT ASSEMBLY INHIBITION 
IN ERYTHROMYCIN TREATED ESCHERICHIA COLI CELLS 
 
by 
 
Jerry E. Usary 
 
Erythromycin has long been recognized for its ability to inhibit protein synthesis by interfering 
with mRNA translation on the bacterial ribosome.  We have recently shown that erythromycin 
also inhibits the assembly of the 50S ribosomal subunit in growing bacterial cells.  The nature of 
this assembly inhibition has been investigated using 3H-uridine pulse-chase labeling of control 
and erythromycin treated E. coli cells. 
 
Subunit assembly was examined by sucrose gradient centrifugation of labeled cell lysates.  
Normal assembly kinetics of subunit assembly were observed in control cells at 37oC.  
Formation of the 30S subunit was completed by 7.5 minutes and assembly of the 50S subunit 
was finished by 15 minutes after an unlabeled uridine chase.  At 37oC, in the presence of 
erythromycin, 30S subunit assembly was unaffected but 50S assembly was greatly reduced. 
When the assembly kinetics were examined at 27oC, the assembly of both subunits was slowed 
and 30-32S precursor particle was seen to accumulate.  This particle was found to bind 14C-
erythromycin  in vivo and in vitro.   
 
RNase E has been implicated in the normal degradation and turnover of rRNA.  A RNase E- 
mutant accumulated substantially more precursor to the 50S subunit than did control cells at 
either 37oC or 27oC.  This precursor particle was also found to bind 14C-erythromycin .  
Specific 50S proteins and the 23S and 5S rRNAs were found in the 30S gradient region from 
lysates of cells grown at 27oC, confirming the presence of a 50S subunit precursor co-
sedimenting with 30S subunits under these conditions.  The precursor particle in the RNase E- 
mutant had a larger number of associated 50S proteins than did the precursor from SK901.  
These data are consistent with our model of 50S subunit inhibition by erythromycin in which a 
fraction of 50S precursor particles undergo normal maturation, while the remainder are 
eventually degraded.  
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CHAPTER 1 
INTRODUCTION 
 
 Isolation of antibiotic resistant bacteria from clinical infections has risen dramatically in 
the past decades.  Our arsenal of effective antibiotics is rapidly diminishing, and researchers are 
seeking new and more effective antimicrobials.  An important step in the search is a better 
understanding of currently used antibiotics, both their targets and mechanisms of action.  The 
effectiveness of some classes of antibiotics results from their specificity for bacterial ribosomes 
and their ability to inhibit protein synthesis during translation. 
 Ribosomes are the cellular organelles that perform the task of protein synthesis.  
 In E. coli, ribosomes constitute 25% of the dried cell mass and a single cell contains about 
15,000 ribosomes (Nierhaus 1982).  Bacterial ribosomes are particles with a sedimentation 
coefficient of 70S and a molecular mass of 2.3 MDa.  They are composed of 2 subunits, a 30S 
(small subunit) and a 50S (large subunit) as shown in Figure 1.  Each of the subunits is a 
ribonucleoprotein complex.  
 In E. coli, the 30S subunit contains a single 16S rRNA molecule (1542 nucleotides) and 
21 different proteins. The 50S subunit has two rRNA molecules, a 23S (2900 nucleotides) and 
a 5S (120 nucleotides) along with 32 proteins (Hardy et al. 1969). 
 The rRNA genes in E. coli  are located in seven rRNA operons in the order 16S-
spacer-23S-spacer-5S.  RNase III cleavage of the pre-rRNA transcript yields precursor 
rRNA molecules that are further trimmed by other ribonucleases into mature molecules.  The 
rRNAs also undergo extensive post-transcriptional methylations (Nierhaus 1982). 
Ribosomal proteins have a molecular weight range of 5.3 to 29.4 kDa.  Many of them 
are small, hydrophobic, and basic with most having a pI in the range of 8.5 and 10 (Giri et al. 
1984).  This neutralizes the negative charges on the phosphates of the rRNA and permits close 
packing of the molecule. 
Ribosomal proteins are designated by either an L or an S (for large or small subunit) 
and a number that corresponds to their migration in a two-dimensional gel system. 
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FIGURE 1.  THE PROKARYOTIC RIBOSOME. 
 
 
 
Source: http://ntri.tamuk.edu/cell/ribosomes.html, 2000. 
 
 The small subunit proteins (S1-S21) are present in 1 copy each except S6, which is 
present in 2 copies.  The protein composition of the large subunit (L1-L34) is more complex.  
Despite the nomenclature, there are 32 different proteins, not 34.  The spot originally identified 
as protein L8 is an aggregation artifact.  The proteins L7 and L12 are identical except that one 
of the serines on the N-terminal of L7 is acetylated.  The large subunit also contains one copy of 
each protein except for L7/L12 which is present as a dimer of dimers (four copies).  In addition, 
S20 is the same protein as L26 (Hardy et al. 1969; Nierhaus 1982). 
 Assembly of ribosomes involves the sequential addition of proteins and conformational 
changes in the growing subunit (Nierhaus 1991).  The order of addition of ribosomal proteins 
during in vitro reconstitution of the 50S subunit has been experimentally determined and is 
shown in Figure 2.  
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FIGURE 2.  E. COLI  50S RIBOSOMAL SUBUNIT ASSEMBLY MAP. 
 Arrows from the rRNA point to proteins capable of binding directly to the rRNA. Thick 
arrows from proteins strongly facilitate the binding of the other proteins to which they point.  
Thin arrows form proteins weakly assist the binding of proteins to which they point.  The 
proteins of the first reconstitution intermediate are above the dashed line and the second 
reconstitution intermediate are below the dashed line. 
 
 
 Source: Nierhaus 1980. 
 
Stable precursor particles that arise in the course of  in vivo ribosome assembly have 
been isolated.  Two precursor particles have been characterized in the assembly process of the 
30S subunit (Hayes and Hayes 1971).  A precursor particle called p130S contains the 16S 
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rRNA, ten small subunit proteins, and has a sedimentation coefficient of 21S.  A  p230S 
particle contains all 21 small subunit proteins, but the final processing of the 16S rRNA has not 
occurred and extra nucleotides are present at the 5’ and 3’ ends. 
 In vivo assembly of the large subunit occurs through 3 stable intermediate precursor 
particles termed p150S,  p250S, and  p350S with sedimentation values of 32S, 43S and about 
50S respectively (Osawa, et al. 1969; Nierhaus, et al. 1973; Lindahl 1975).  These particles all 
contain 23S and 5S rRNAs and increasing subsets of proteins. 
 The synthesis of ribosome components is highly regulated.  More ribosomes are needed 
to carry out additional protein synthesis when nutrient levels or environmental conditions 
become more favorable for growth.  When conditions are limiting, it becomes energetically 
expensive to produce unneeded ribosomes.  Additionally, it is important that the cell maintain 
stoichemetric production of ribosomal components (Dennis 1974; Champney 1977).   
 Regulation is maintained through 2 negative feedback loops which operate at both the 
transcriptional and translational levels (Nomura 1983).  When amino acid supplies are low, 
deacylated tRNAs bind the 30S subunit and trigger synthesis of an allosteric factor that acts to 
down-regulate transcription of both the rRNA and mRNAs for the ribosomal proteins.  When 
more nutrients become available acetylated tRNAs bind the 30S subunit, production of the 
stringent factor ceases, and ribosome biosynthesis resumes.  Translational control occurs when 
there is no free rRNA to begin assembly of a new subunit.  Some ribosomal proteins act as 
repressors by binding to the mRNAs of other ribosomal proteins and halting their translation.    
 Degradation of ribosomes in vivo is mediated via a multicomponent ribonucleolytic 
complex termed the degradosome (Bessarab et al. 1998).  An important component of the 
degradosome is RNase E, an endonuclease that cleaves the 16S and 23S RNAs (Miczak et al. 
1996).  Other degradosome-associated enzymes, including polynucleotide phosphorylase and 
RNA helicase, continue the process of ribosome turnover.  RNase E has previously been 
identified as an enzyme involved in mRNA and rRNA turnover but not in the processing of 
tRNA (Kusnher et al. 1993; Coburn and Mackie 1998). 
 The information for each step and conformational change in the assembly pathway lies in 
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the molecular components of the ribosome.  The information for the secondary and tertiary 
structure of the ribosome is present in the primary sequences of the rRNA and proteins (Piccon 
et al. 1975).  This is demonstrated by the fact that functional ribosomes can be reconstituted in 
vitro from isolated components with high efficiency (Amils et al. 1979). 
 Reconstitution of the 30S subunit in vitro proceeds through only one reconstitution 
intermediate termed RI30.  The RI30 intermediate can be isolated if 16S RNA and TP30 (total 
proteins extracted from the 30S subunit) are incubated together in a reaction buffer at 0oC 
(Guthrie et al. 1969).  If the reaction temperature is increased to 40oC, the RI30 undergoes a 
rate limiting conformational change to an RI*30  particle and the remaining proteins are then 
assembled onto the forming 30S subunit (Traub et al. 1971; Nierhaus et al. 1973).  
 Reconstitution of the 50S subunit requires a two-step procedure using different 
temperatures and concentrations of magnesium.  Three stable intermediate precursor particles 
can be isolated during the in vitro reconstitution process (Dohme and Nierhaus 1976).  These 
have been termed RI50(1), RI50*(1),  and RI50(2).  The RI50(1) and RI50*(1) contain the 
same rRNAs and protein subset but have very different sedimentation coefficients of 33S 
[RI50(1)] and 41S [RI50*(1)] because of a conformational change in the particle.  The RI50(2) 
particle contains all the proteins found in the fully formed 50S subunit but is completely inactive 
in translation assays.  A second conformational change that is both temperature and magnesium 
dependent results in an active 50S subunit (Osawa et al. 1969; Nierhaus 1991). 
 The ribosome has 4 binding sites that are used in protein synthesis.  The peptidyl-tRNA 
binding site (P-site) holds a tRNA attached to the growing polypeptide.  The aminoacyl-tRNA 
binding site (A-site) holds an incoming tRNA attached to an amino acid.  An exit site (E-site) 
briefly holds the departing tRNA before it is released.  The 3' end of  the16S rRNA contains a 
binding site that base pairs with the Shine-Dalgarno recognition sequence on the mRNA.  
 Protein synthesis in prokaryotes proceeds through three steps, initiation, elongation, and 
termination.  These are shown in Figures 3, 4, and 5. (For a review, see Nierhaus 1982).
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FIGURE 3.   INITIATION OF PROTEIN SYNTHESIS. 
 
 
 
 Source: http://ntri.tamuk.edu/cell/ribosomes.html, 2000. 
 
 During the initiation step, 3 initiation factor proteins (IF1, IF2, and IF3) transiently 
associate with the free 30S subunit.  An F-met-tRNA complex attaches to the P-site of the 
small subunit.  The small subunit attaches to the 5'-end of an mRNA and slides along it until the 
tRNA-F-met anticodon recognizes an AUG codon and stops.  GTP is hydrolyzed, initiation 
factors are released, and the remaining complex binds to the 50S subunit.  An aminoacyl tRNA 
then enters the A-site and chain elongation begins.  
The elongation step is a cyclic process that is repeated for each amino acid that is 
added to the growing polypeptide. The next aminoacyl-tRNA is brought to the vacant A-site of 
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the ribosome by elongation factor EF-TU. 
FIGURE 4.  ELONGATION OF THE POLYPEPTIDE. 
 
 
 
 Source: http://ntri.tamuk.edu/cell/ribosomes.html, 2000. 
  
 The carboxyl-end of the nascent peptide attached to the tRNA in the P-site is detached 
and reattached by a peptide bond to the amino-end of the amino acid attached to the tRNA in 
the A-site.  The protein is now one amino acid longer, but it is bound as peptidyl-tRNA in the 
A-site.  Peptide bond formation occurs at the peptidyl transferase center on the 50S subunit.  
The activity is believed to be mediated by the 23S rRNA because removal of many proteins 
from the 50S subunit does not abolish the peptidyl transferase activity of the remaining rRNA. 
 The peptidyl-tRNA is then translocated from the A site to the P site and the empty  
tRNA moves to the E site and dissociates from the ribosome.  This translocation step requires 
EF-G and GTP hydrolysis.  During translocation, the ribosome shifts three bases along the 
mRNA and moves a new codon into the A-site to make room for the next incoming 
aminoacylated tRNA.  The elongation cycle is repeated until all the amino acids that are 
specified by that mRNA have been added. 
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FIGURE 5.  TERMINATION OF PROTEIN SYNTHESIS.                                                 
 
 
 Source: http://ntri.tamuk.edu/cell/ribosomes.html, 2000. 
 
 Termination occurs when 1 of 3 stop codons enters the A-site on the ribosome and 
signals that the polypeptide is complete.  Release factors cause the complex to disassociate, 
releasing the polypeptide chain.  The ribosome detaches from the mRNA and dissociates into 
30S and 50S subunits that are free to begin another round of translation (Nierhaus 1982).   
 Protein synthesis in bacteria occurs very rapidly.  It begins as the mRNA is still being 
transcribed from the DNA and a single mRNA molecule can serve as template for many 
ribosomes translating simultaneously. 
 A number of antibiotics that act on the ribosome are derived from bacteria.  Those 
obtained from the actinomycete Streptomyces include the aminoglycosides, tetracyclines, and 
macrolides (Cundliffe 1980).  The aminoglycosides include streptomycin, kanamycin, 
tobramycin, and gentamicin.  They act by binding to bacterial ribosomes and preventing the 
initiation of protein synthesis.  The tetracyclines (including tetracycline, chlortetracycline, and 
doxycycline) are broad-spectrum antibiotics that act by blocking the binding of aminoacyl tRNA 
to the A-site on the ribosome.  The macrolides (including erythromycin and oleandomycin) halt 
bacterial protein synthesis by binding to the 50S ribosomal subunit.  The bound antibiotic either 
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inhibits elongation of the protein by peptidyl transferase or prevents translocation of the 
ribosome or both (Corcoran 1984). 
  Erythromycin and related macrolide antibiotics are effective against a variety of Gram 
positive and Gram negative bacteria.  Erythromycin has a 14-member macrolactone ring to 
which an amino sugar and a neutral sugar are attached through glycosidic bonds (Nakagawa 
and Omura 1984).  The structures of erythromycin, azithromycin and oleandomycin are shown 
in Figure 6.  
Currently, several semi-synthetic derivatives of erythromycin such as azithromycin and 
clarithromycin are used to treat clinical infections.  These compounds are more acid stable as 
they pass through the digestive tract and are effective against a broader spectrum of microbes 
(Whitman and Tunkel 1992; Champney 1999). 
 Erythromycin binds stiochimetrically with a 1:1 ratio to the 50S subunit (Pestka 1974).  
The binding site has been identified as the central loop of domain V in the 23S rRNA, part of 
the peptidyl transferase region (Douthwaite et al. 1985; Douthwaite et al. 1995).  Proteins L15 
and L16 also have been directly implicated in erythromycin binding (Teraoka and Nierhaus 
1978). 
 Macrolide resistance most commonly occurs due to the action of a plasmid encoded 
methyltransferase (Corcoran 1984).  Dimethylation of a single adenine residue at position 
A2058 in the 23S RNA results in 50S subunits that are unable to bind the antibiotics.  
Resistance to macrolides also is associated with mutational changes in large subunit proteins, 
particularly L4 and L22 (Teraoka and Nierhaus 1978; Chittum and Champney 1994). 
Previous investigations of macrolide activity have focused on their ability to inhibit 
protein synthesis (Gale et al. 1981; Moazed and Noller 1987).  Our lab recently has discovered 
that inhibition of 50S ribosomal subunit assembly in growing cells is a second novel activity of 
erythromycin (Chittum and Champney 1995).  
In the presence of erythromycin, the normal sequence of 50S subunit assembly is 
interrupted leading to a "stalled" intermediate precursor particle that becomes a target for 
degradation by cellular ribonucleases. 
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FIGURE 6.  STRUCTURES OF ERYTHROMYCIN, AZITHROMYCIN AND 
OLEANDOMYCIN. 
 
  
A.  Erythromycin.     B.  Azithromycin. 
 
 
 
 
C.  Oleandomycin. 
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 Further, 50S subunit assembly inhibition has been found to be as important as protein 
synthesis inhibition in accounting for overall growth inhibition (Champney and Burdine 1996).  
 It is my hypothesis that in the presence of erythromycin, the stalled 50S intermediate 
precursor will accumulate in growing cells and that it will bind to erythromycin.  It will contain 
the 23S and 5S rRNAs along with only a subset of 50S subunit proteins and it will lack 
sufficient density to sediment into the 50S gradient region.  I hypothesize that the stalled 50S 
subunit precursor will accumulate in greater amounts in E. coli cells deficient in a key rRNA 
ribonuclease.  I further hypothesize that the inhibition of 50S subunit assembly by erythromycin 
will occur during an in vitro reconstitution of the 50S subunit.  
 Several methods were used to test the validity of this hypothesis.  An evaluation of the 
kinetics of formation and degradation of the precursor was done in a K12 strain of E. coli 
(SK901).  An RNase E temperature-sensitive mutant strain (SK5665) was used to evaluate the 
role of the RNase E in 50S precursor turnover (Altman et al. 1982; Babitzke et al. 1993).   
 To assess the ability of the 50S precursor particle to bind erythromycin, a crucial step in 
the drug’s mechanism of action, the binding of 14C-erythromycin  to the precursor was 
measured using in vivo and in vitro studies.  The presence of 23S rRNA and 5S rRNA in the 
50S subunit intermediate precursor was determined by polyacrylamide gel electrophoresis and 
nucleic acid hybridization experiments.  The 50S subunit proteins  in the intermediate precursor 
were identified via two-dimensional gel electrophoresis.   
 To determine if the in vivo inhibition of 50S subunit assembly could be mimicked in 
vitro, reconstitution experiments using 30S and 50S subunits in the presence and absence of 
several antibiotics were performed. The sedimentation properties of the ribosomal subunit 
reconstitution products were determined via sucrose gradient centrifugation. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
Materials 
 
Erythromycin, oleandomycin, formaldehyde, N,N,N’,N’-tetramethyl-ethylenediamine 
(TEMED), thymidine, thiamin, and lysozyme were purchased from Sigma Chemical Co.  The 3-
(N-morpholino)propanesulfonic acid (MOPS), 4-(2-hydroxyethyl)-1-piperazine-ethane sulfonic 
acid (HEPES), sodium dodecyl sulfate (SDS), formamide, trichloro-acetic acid (TCA), 
scintisafe gel, agar, and urea were purchased from Fisher.  Azithromycin was a gift from Pfizer 
Pharmaceuticals.  Tryptone and casein were purchased from Difco Laboratories.  DNAse 1 
was purchased from Amresco.  Lumiphos reagent and streptavidin-alkaline phosphatase 
conjugate were purchased from Scheichler & Schuell.  The radioactive compounds 14C-
erythromycin (54 mCi/mM) and 3H-uridine (40 Ci/mM) were purchased from New England 
Nuclear and the 35S-methionine-cysteine mixture (1175 Ci/mM) was purchased from ICN 
Biomedicals.  Acrylamide, bis-acrylamide, protein assay kit, and bis-tris(hydroxymethyl) 
aminomethane(Bis-Tris) were purchased from Bio-Rad.  Proteinase K and the 5S, 16S, and 
23S rRNA standards were purchased from Boehringer-Mannheim.  X-ray film was purchased 
from Fujifilm.  Polaroid film (types P/N52 and P/N55) and comassie blue was purchased from 
Kodak Co. PCR primers were obtained from Life Technologies.  The PCR Super-Mix was 
purchased from Gibco BRL.  The Label-It probe biotinylation kit was purchased from CPG 
Inc.  Salmon sperm DNA was purchased from Promega.  The dialysis tubing was purchased 
from Spectrum Medical Industries Inc.  Nitrocellulose filters were purchased from Millipore.  
The GF/A glass fiber filters and Number 3 blotting paper were purchased from Whatman 
International. 
Bacterial Strains 
 
Five strains of E. coli were examined, a wild type strain SK901 (see Table 1) and 4 
mutant strains with enhanced erythromycin sensitivity. 
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Table 1.  E. coli  Strains Used in this Research. 
______________________________________________________________ 
Name                    Genotype                                                            Reference 
SK901   K12, F-, malA-, thi-  (Champney 1979, 1983) 
SK5665 K12, F-, thyA715, l-, rne-1 (Babitzke et al. 1993) 
SK1217 K12, F-, ts, spcHS, pro-, eryHS (Champney 1979)  
SK1219 K12, F-, ts, spcR, pro-, eryHS (Champney 1979) 
MRE600 rnase1-, eryHS   (Held and Normura 1973)
 
______________________________________________________________ 
 
Media 
 
Luria Broth:  10 g tryptone, 10 g NaCl, 5 g yeast extract  to 1 L with deionized water (dH2O). 
Luria Plates: Luria broth and 1.5% agar. 
Tryptone Broth:  10 g tryptone and 10 g NaCl to 1 L with dH2O. 
5X A-salts: 52.5 g K2HPO4,  22.5 g KH2PO4, 5 g (NH4) 2SO4, and 2.5 g Na 
citrate×(2H2O) to 1 L with dH2O. 
Minimal Media:  100 ml 1X A-salts, 1 ml 20% glucose, 0.1 ml 20% MgSO4 , and 0.05 ml 
thiamin [1mg/ml]. 
 
Buffers 
 
Ribosome Buffers 
R-Buffer: 10 mM Tris-HCl (pH 8.0), 10 mM Mg acetate, 50  mM NH4Cl. 
S-Buffer: 10 mM Tris-HCl (pH 8.0), 0.5 mM Mg acetate, 100  mM NH4Cl. 
Ribosome Wash 1: 10 mM Tris-HCl (pH 8.0), 2 M NH4Cl, 10 mM Mg acetate, 10% 
sucrose. 
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Hybridization Buffers 
Modified Church buffer: 1 mM EDTA, 1% casein, 7% SDS, 0.25 M Na2HPO4 (7 H2O) and 
H3PO4 to adjust pH to 7.4. 
20X SSC: 3.0 M NaCl, 0.3 M Na citrate and HCl to adjust pH to 7.0. 
 
rRNA Electrophoresis Buffers 
10X TE buffer: 0.89 M Tris-HCl (pH 8.0), 25 mM EDTA. 
10X MOPS buffer: 200 mM  MOPS (pH 2.0), 50 mM sodium acetate, 5 mM EDTA. 
 
Protein Electrophoresis Buffers 
1st dimension sample buffer: 0.1 ml of 1 M Bis-Tris (pH 4.2), 9.6 ml of 8 M urea, 0.06 ml 
acetic acid, 0.1 ml mercaptoethanol and dH2O to 10 ml. 
1st dimension upper tank buffer: 10 ml 1M Bis-Tris (pH 3.8) and 3.6 ml acetic acid to 1 L with 
dH2O . 
1st dimension lower tank buffer:  10 ml 1 M Bis-Tris (pH 6.0) and 0.4 ml acetic acid 
to 1 L with dH2O. 
1st
 
dimension separating gel solution: 4 ml 1 M Bis-Tris (pH 5.5), 0.45 ml acetic acid, 4 gm 
acrylamide, 132 mg bis-acrylamide and 48 gm urea to 100 ml with dH2O. 
2nd dimension separating gel solution: 180 ml glacial acetic acid (pH 4.5), 2.7 gm KOH, 180 gm 
acrylamide, 2.5 gm bis-acrylamide and 360 gm urea to 1 liter with dH2O. 
2nd dimension running buffer: 1.5 ml glacial acetic acid (pH 4.0) and 14 gm glycine to 1 liter with 
dH2O. 
 
Reconstitution Buffers 
Buffer #4: 20 mM Tris-HCl (pH 6.0), 4 mM Mg acetate, 400 mM NH4Cl, 0.2 mM EDTA 
and 5 mM 2- mercaptoethanol. 
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Buffer #5: 20 mM Tris-HCl (pH 6.0), 6 M urea, 4 mM Mg acetate, 400  mM NH4Cl, 0.2 mM 
EDTA and 5 mM 2- mercaptoethanol.     
Buffer # 6: 20 mM Tris-HCl (pH 6.0), 20 mM Mg acetate, 400 mM NH4Cl, 1 mM EDTA  
and 5 mM 2- mercaptoethanol.  
Buffer #7: 10 mM Tris-HCl (pH 7.6) and 4 mM Mg acetate. 
Buffer # 9: 110 mM Tris-HCl (pH 8.0), 4 mM Mg acetate, 4 M NH4Cl, 0.2 mM EDTA and 
20 mM 2- mercaptoethanol. 
Buffer P: 10 mM Tris-HCl (pH 6.0), 2 mM Mg acetate and 1 mM 2- mercaptoethanol. 
 
 
Methods 
 
 Cell Culture 
 Bacterial strains were maintained at -80oC in 1ml aliquots of Luria broth (L broth) 
containing 20% glycerol.  Cells were grown in an incubator at 32oC or 37oC after being 
streaked onto plates containing L broth and 1.5% agar.  Individual colonies were used to 
inoculate 1 ml overnight cultures of L broth. 
Small scale cell culture was done in a shaking water bath at 27oC or 37oC. 
Cells were grown in side arm flasks, and the density was monitored using a Klett-Summerson  
colorimeter.  One hundred Klett units equals 1 unit of optical density at 600 nm or 
approximately 8x108  cells/ml.  Ten ml of growth media were inoculated with cells from an 
overnight culture to a Klett unit reading of 20.  After growth to 80 Klett units, cells were chilled 
on ice and collected into 15 ml round bottom Corex tubes then centrifuged for 30 minutes at 
9000 rpm (9,800 xg).  The supernatant was discarded and the pellet was rinsed in 200 ml of S-
buffer and stored at -80oC. 
 Large scale cell culture was done on a shaking platform in a Bally environmental room 
at 32oC.  One liter of sterile L Broth was inoculated with 2.0 ml of an overnight culture.  Media 
for strain SK5665 was supplemented with thymidine at 5 mg/ml.  Cell densities were determined 
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by reading the absorbance at 600 nm in a Beckman model 35 spectrophotometer. 
 
 Determination of Minimal Inhibitory Concentration (MIC) 
 The minimal inhibitory concentration for each antibiotic used was determined by a 
dilution method.  Tubes containing 1 ml of LB were inoculated with 50 ml of E. coli  cells from 
an overnight culture.  Different concentrations of antibiotics were added to each tube and the 
cells were incubated overnight at 32oC.  Growth was measured by reading the absorbance at 
600 nm.  Concentrations of each antibiotic were chosen for each strain that reduced cell growth 
without halting it entirely. 
 
Sucrose Gradient Fractionation 
 Linear sucrose gradients (12 ml) of 5-20% sucrose in S-buffer were constructed in 14 
ml Seton polyallomer centrifuge tubes.  Samples of either 70S ribosomes or cell lysates were 
layered on top of the gradients.  Tubes were centrifuged four hours at 39,000 rpm (284,000 xg) 
in a Beckman L5-65 or LE-80K preparative ultracentrifuge using an SW40 rotor.  Gradients 
were fractionated through an ISCO UA-5 absorbance monitor and fractions of six drops each 
were collected.  Standard curves for 70S ribosomes and 30S and 50S subunits were obtained 
using an analog-digital signal converter along with Dynamax capture and integration software 
(Ranin). 
  
Isolation of 70S Ribosomes 
 Each cell pellet was resuspended in 5 ml R-buffer and 0.2 ml of freshly made lysozyme 
(2 mg/ml in R-buffer) was added.  Tubes were incubated 5 minutes at room temperature, then 
frozen and thawed three times using a dry ice/ethanol bath. 
RNase free DNase 1 (40 units) was added and the tubes were incubated at room 
temperature for 5 minutes.  Cell debris was pelleted by centrifugation in a JA-20 rotor at 
10,000 rpm (12,100 xg) for 30 minutes at 4oC.  The supernatant was transferred to stainless 
steel tubes and spun in a Ti 50 rotor at 30,000 rpm (240,000 xg) for 30 minutes at 4oC to pellet 
intermediate sized cell debris.  Finally, the supernatant was transferred to other stainless steel 
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tubes and spun at 45,000 rpm (300,000 xg) for 3 hours to pellet the crude 70S ribosomes.  
The pelleted ribosomes were resuspended in 0.5-1.0 ml R-buffer and the concentration was 
quantitated by measuring the absorbance at 260 nm (A260).  One optical density unit of 70S 
ribosomes at A260 =  26 pmol/ml (Stanley and Bock 1965).  The ribosomes were stored at -
80oC. 
  
Washing of Crude 70S Ribosomes 
 The resuspended crude 70S ribosomes were layered over an equal volume of 
Ribosome Wash 1 in sterile stainless steel tubes.  The tubes were spun for 3 hours in a Ti 50 
rotor 45,000 rpm (300,000 xg) at 4oC to pellet the washed 70S ribosomes.  The supernatant 
was discarded, and the pellets resuspended in 0.5-1.0 ml R-buffer and stored at -80oC. 
 
Separation of 70S Ribosomes into 50S and 30S Subunits 
 Washed 70S ribosomes (150 A260 units) were loaded onto 38 ml gradients (5-20% 
S-buffered sucrose) and spun in an SW 27 rotor at 18,000 rpm for 18 hours (30,000 xg).  
Gradients were fractionated through an ISCO monitor and pools of the 30S and 50S peaks 
were collected separately in sterile 30 ml round bottom Corex tubes.  One M Mg acetate was 
used to raise the concentration of magnesium ions to 20 mM and the solution was mixed with an 
equal volume of 100% ethanol. 
 After 1 hour at -20oC, the precipitated subunits were centrifuged at 10,000 rpm for 30 
minutes.  The resulting pellet was dried, then resuspended in a small volume of R-buffer, the 
concentration was quantitated by absorbance at 260 nm, and stored -80oC.  One optical 
density unit of 30S subunits at 260 nm =  76 pmol/ml.  One optical density unit of 50S subunits 
at 260 nm =  44 pmol/ml (Stanley and Bock 1965). 
 
3H-uridine Pulse-Chase Labeling 
 Cells were grown in selected medium to approximately 20 Klett units at either 27oC or 
37oC.  The antibiotic used for the particular experiment was added at concentrations 
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determined by the MIC assays.  Growth was continued until approximately 80 Klett units (two 
cell doublings).  The RNA was pulse-labeled by adding 3H-uridine [5 mCi/ml], incubating for 90 
seconds, and chasing with a 50X excess of unlabeled uridine [20 mg/ml].  Aliquots of cells were 
harvested to chilled tubes at specified time intervals.  They were spun down, washed in 200-
500 ml of S-buffer, re-pelleted and held at -80oC until lysis.  In some experiments, 14C-
erythromycin was added at 75 mg/ml for SK901 or 18 mg/ml for SK5665. 
 
Protocol for Pulse-Chase Cell Pellet Lysis 
 The cell pellet was thawed and resuspended in 0.2 ml of S-buffer.  Five ml of lysozyme 
[5 mg/ul], freshly made in S-buffer, was added to the Corex tubes.  The tubes were incubated 
for 5 minutes at room temperature, then frozen and thawed 3 times using a dry ice/ethanol bath.  
RNase free DNase 1 (4 units) was added and the tubes were incubated at room temperature 
for 5 minutes.  Large cell debris was pelleted by centrifugation at 10,000 rpm (12,100 xg) for 
20 minutes at 4oC and the supernatant from each pellet was applied to a sucrose gradient. 
 
Isolation of Total rRNA from 70S Ribosomes 
 70S ribosomes were resuspended in 0.5 ml of R-buffer and extracted 3 times with 1.0 
volume of  Tris-saturated phenol made 1% in SDS.  The aqueous phase containing the rRNA 
was then extracted with an equal volume of chloroform/isoamyl alcohol (24/1 v/v).  The rRNA 
was precipitated by adding 2 volumes of ice-cold absolute ethanol and placing the samples at -
20oC for 2 hours. 
 The dried 70S rRNA pellet was resuspended in a minimal volume of  R-buffer (or 
buffer #7 if the rRNA was to be used for reconstitutions), quantitated by reading the 
absorbance at 260 nm and stored at -80oC.  One optical density unit of total rRNA from 70S 
ribosomes at 260 nm contains 26 pmol each of the 23S, 16S, and 5S rRNA species (Stanley 
and Bock 1965). 
 
Isolation of Proteins from Ribosomes and Subunits 
 One molar Mg acetate (0.1 volume) and glacial acetic acid (2 volumes) were added to 
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ribosomal subunits or ribosomes suspended in R-buffer.  The mixture was held on ice for 1 hour 
to precipitate the rRNA.  
After centrifugation in a JA-20 rotor at 7,500 rpm (6,800 xg) for 30 minutes, the 
supernatant containing the proteins was transferred to fresh tubes and acetone (5-7 volumes) 
was added.  Samples were kept at -20oC overnight to precipitate the proteins, centrifuged again 
in a JA-20 rotor at 7,500 rpm (6,800 xg) for 30 minutes, and the protein pellet air dried in a 
44oC incubator. 
 The 30S or 50S ribosomal protein pellet was resuspended in 0.5-1 ml of buffer #5, 
then dialyzed three times (45 minutes each) against 100 volumes of buffer #4.  The 50S proteins 
were then dialyzed twice (45 minutes each) against 100 volumes of buffer P.  Final protein 
concentrations were determined by using a protein assay dye reagent kit (Bio-Rad) and aliquots 
were stored at -80oC. 
 
Ribosomal Subunit Reconstitution Methods  
 All reconstitution experiments used ribosomal subunits from strain MRE600.  
Reconstitution of 30S ribosomal subunits was accomplished using a single-step incubation of 
isolated 16S rRNA and TP30.  16S rRNA (0.75 A260 units) was resuspended  in 10 ml of 
buffer # 7.  0.1 volume of buffer # 9 was added to create ionic conditions the same as buffer 
#4.  TP30 (1.5-3 e.u. in buffer # 4) was added to the reaction along with a sufficient amount of 
buffer # 4 to bring the total volume to 100 ml. 
 Tubes were incubated in a water bath for 20 minutes at 40oC then chilled on ice.  
Sedimentation properties of the products were analyzed by sucrose gradient centrifugation using 
5-20% R-buffered sucrose in an SW50.1 rotor.  Samples were spun at 49,000 rpm (224,000 
xg) for 2 hr at 4oC. 
 Reconstitution of 50S ribosomal subunits was accomplished using a 2-step incubation of 
isolated 70S rRNA and TP50.  3.8 A260 units of 70S rRNA was resuspended in 15 ml of 
buffer #7.  0.1 volume of buffer # 9 was added to create ionic conditions the same as buffer #4.  
Sufficient Tris-HCl, Mg acetate, NH4Cl, EDTA, and mercaptoethanol were added to the TP50 
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in buffer P to change the ionic conditions to that of buffer #4.  Eighty-five ml of the TP50 (5-6 
e.u. in buffer #4 now) was added to the reaction along with a sufficient amount of buffer # 4 to 
bring the total volume to 120 ml.  
 The first incubation was done in a water bath at 44oC for 30 minutes.  One M Mg 
acetate was added to increase the magnesium ion concentration to 20 mM and the tubes were 
transferred to a 50oC bath for 90 minutes.  Sedimentation properties of the products were 
analyzed by sucrose gradient centrifugation using 5-20% R-buffered sucrose in an SW50.1 
rotor at 49,000 rpm (224,000 xg) for 2 hours at 4oC. 
   
Polymerase Chain Reaction (PCR)  
 The nucleotide sequence of the 23S rRNA was examined using the oligonucleotide 
analysis program Oligo (National Biosciences).  Suitable primer pairs were selected for the 
PCR amplification of  a 23S rRNA hybridization probe and were obtained from Gibco BRL 
Custom Primers.  The selected probe was complementary to the central region of the 23S 
rRNA (nucleotides 1188-1334).  
Fifty ml PCR reactions were constructed using 45 ml PCR SuperMix High Fidelity 
reagent mixture (Gibco BRL), 1 ml of plasmid pKK template DNA (6.5 ng), 1 ml (10 pmol) 
forward primer (sequence 5’ TAG GGG AGC GTT CTG TAA G 3’), 1 ml (10 pmol) reverse 
primer (sequence 5’ CCC GAT TAA CGT TGG AC 3’), and 2 ml dH2O.  Samples were 
placed in a PTC-100 programmable thermocycler (MJ Research) for thirty cycles under the 
following conditions:  Denaturation at 94oC for 2 minutes, annealing of primers to target DNA at 
55oC for 2 minutes and extension of the primers at 72oC for 1.5 minutes.  To insure 
homogeneity of the 146 base pair PCR product, five ml from each reaction mixture were 
examined on a 2% agarose gel along with molecular weight markers.  The 23S DNA probe 
was biotinylated using a Label-It 3’ Biotin End Labeling Kit (CPG Inc.) following manufacturers 
instructions.  Product labeling was checked by comparison to a prelabeled oligonucleotide 
provided with the kit.  
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rRNA Hybridization 
 Pulse-chase experiments were performed as described and the cell lysates were applied 
to sucrose gradients.  Fractions were collected and 10 ml of a 10% SDS solution containing 5 
mg Proteinase K were added to each tube.  The tubes were then incubated at 44oC for 30 
minutes.  The samples were applied to a 7 x 10 cm nylon membrane with a pore size of 0.2 mm 
(Scheichler & Schuell) using a Bio-Dot apparatus (BioRad).  After blotting, samples were 
cross-linked by UV irradiation at 254 nm (120 mJ/cm2). 
 A hybridization incubator (Fisher-Biotech) was used to prehybridize the membrane at 
65oC for 1-2 hours with 5 ml modified Church’s buffer solution containing 10 mg/ml denatured 
herring sperm DNA (Promega).  Biotin labeled probe was denatured by heating to 65oC for 15 
minutes in a solution containing 50% formamide, 6% formaldehyde and 1X MOPS then quick 
cooled on ice.  Four pmol of denatured probe per membrane was added and allowed to 
hybridize overnight at 65oC.   
 All washes and rinses were done in hybridization bottles.  The membrane was rinsed 
with 10 ml of  5X SSC, 0.1% SDS, then washed at 65oC with 10 ml of  5X SSC, 0.1% SDS 
for 15 minutes, at 45oC with 10 ml of  2X SSC, 0.1% SDS for 15 minutes, and at 40oC with 
10 ml of  1X SSC, 0.1% SDS for 15 minutes.  Then, 0.5 ng streptavidin-alkaline phosphatase 
enzyme was added to 10 ml of 1X SSC, 0.1% SDS and the membrane was washed exactly 10 
minutes with this solution.  The membrane was rinsed twice in 10 ml 1X SSC 0.1% SDS, 
washed at room temperature for 15 minutes with 10 ml 1X SSC 0.1% SDS, and rinsed in 
sterile deionized water.  Lumiphos reagent was sprayed on the membrane and it was kept in 
darkness for 1 hour and then exposed to Fuji RX medical X-ray film.  The film was developed 
in Kodak GBX developer for 5 minutes, rinsed in water and fixed with Kodak GBX fixer for 5 
minutes. 
 
Polyacrylamide Gel Electrophoresis of RNA  
 Sucrose gradient fractions of subunits were transferred to 1.5 ml microfuge tubes and 
10 ml of a 10% SDS solution containing 5 mg Proteinase K was added to each tube, which 
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were then incubated at 44oC for 30 minutes.  One molar sodium acetate (0.1 vol.) and absolute 
ethanol (2 vol.)  were added and tubes were kept at -20oC for 2 hours.  The rRNA was 
pelleted by centrifugation in a microcentrifuge at 10,000 rpm (7,200 xg), rinsed with 70% 
ethanol and respun, then dried in a 44oC incubator. 
 The rRNA pellets were resuspended in 10 ml  of denaturing solution (50% formamide, 
6% formaldehyde and 1X MOPS),  heated at 65oC for 15 minutes and quick cooled on ice.  
Five ml of 80% glycerin / 1% bromo-phenol blue was added and the samples were 
electrophoresed on a 4% / 7% polyacrylamide gel at 200V for 1.5 hours in 0.5X MOPS 
buffer.  For fluorography, gels were soaked for 30 minutes in 1 M sodium salicylate, dried 
under vacuum onto Whatman Number 3 paper and exposed to X-ray film at -80oC. 
 
  Erythromycin Binding Assays 
  In vivo binding: 
 
Dual labeling experiments were performed as follows: 14C-erythromycin  
at 18 mg/ml (1.2 mCi/ml) was added to growing cells at approximately 20 Klett units.  At about 
80 Klett units, a 3H-uridine pulse-chase assay was performed as described.  Cells were 
collected at 15 minutes post-chase, lysed, and gradient fractionated.  Fractions corresponding 
to 30S and 50S regions were pooled separately, then the absorbance at 260 nm was read.  The
 
amounts of 3H-uridine and
 
14C-erythromycin  in each pool were measured by liquid scintillation 
counting in a Beckman LS-3801 instrument.   
 In vitro binding:  SK901 cells were grown at 27oC with and without erythromycin at 75 
mg/ml.  Ribosomal subunits and precursor particles from appropriate gradient  fractions were 
pooled and dialyzed to remove the sucrose and unlabeled erythromycin. 14C-erythromycin  at 
18 mg/ml (1.2 mCi/ml) was added and the pools were incubated at 37oC for 15 minutes.  The 
subunits were captured on a Millipore 0.45 micron filter, washed 3 times with 1 ml of R buffer 
and counted for bound erythromycin. 
 
Two-Dimensional Gel Electrophoresis of Ribosomal Proteins 
 Cells were grown in minimal media at 27oC.  At about 30 Klett units, 50 mCi/ml of a 
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35
S-methionine-cysteine mixture was added and growth was allowed to continue.  At 80 Klett 
units, cells were harvested as described, lysed and fractionated on a 5-20% sucrose gradient.  
Samples were collected that contained the top, 30S, and 50S gradient regions.  The samples 
were sealed in 3,500 molecular weight cut off tubing (Spectrapor) and dialyzed overnight 
against three changes (500 ml each) of R-buffer.  Proteins from the entire top pool or from eight 
A260 units of subunits from the 30S and 50S pools were extracted by acetic acid/acetone as 
described.  The dried proteins were resuspended in 50 ml of 1st dimension sample buffer. 
 First dimension gels:  Glass tubes (0.2 X 10 cm) were filled with 0.4 ml of separating gel 
and polymerized with 1 ml/ml TEMED and 3 ml/ml of 10% ammonium persulfate.  Samples 
were electrophoresed 30 minutes at 60V then for 5 hours at 150 volts.  In the upper tank, 250 
ml of 1st
 
dimension upper tank buffer (pH 3.8) was used.  In the lower tank, 250 ml of 1st 
dimension lower tank buffer (pH 6.0) was used. 
 Second dimension gels:  Gels were cast in a Hoefer SE 500 slab gel apparatus using 60 
ml of  two-dimensional (2-D) gel solution that had been mixed with 1.2 ml of 10% ammonium 
persulfate, and 300 ml of TEMED.  After the first dimension run, the gels were removed from 
the glass tubes and polymerized atop the second dimension gels. 
 Electrophoresis was carried out with the cathode on top using 400 ml of 1 X  2-D 
running buffer in the upper tank and 1200 ml of 0.3X 2-D running buffer in the lower tank.  The 
proteins were stacked at 40 volts for 1 hour followed by 100 volts for 13 hours.  
 The gels were stained a solution of 0.1% Coomassie Brilliant Blue R-250, 7.5 % acetic 
acid, and 50% methanol. They were destained in a mixture of  5% glacial acetic acid and 10% 
ethanol.  After destaining, the gel slabs were photographed using a digital camera (Alpha 
Innotec). 
 For fluorography, gels were soaked for 30 minutes in 1M sodium salicylate, dried under 
vacuum onto Whatman Number 3 paper and exposed to X-ray film at -80oC.  For quantitation, 
gel spots were excised using a cork borer and dissolved in 0.5 ml of 30% hydrogen peroxide 
for 8 hours at 80oC.  Samples were mixed with 3 ml of Scintisafe cocktail and the radioactivity 
was measured in a liquid scintillation counter.    
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CHAPTER 3 
RESULTS 
 
 Previous investigations have shown that the macrolide antibiotics erythromycin, 
azithromycin, and oleandomycin inhibit 50S ribosomal subunit formation in Escherichia coli, 
Bacillus subtilis and Staphylococcus aureus cells (Champney 1999).  Further characteristics of 
assembly inhibition were investigated in E. coli  because of the availibility of mutant strains and 
because the ribosomes of E. coli have been well studied (Hampl et al. 1981; Nierhaus 1982). 
 A wild type strain SK901 and 4 mutant strains with enhanced erythromycin sensitivity 
(see Tables 1 and 2) were initially examined for the effects of the three macrolide antibiotics on 
growth and protein synthesis rates.   
 
 
Macrolide Effects on Cell Growth 
 
Experiments were conducted to find concentrations of antibiotics that inhibited growth 
but did not halt it entirely.  Concentrations of each antibiotic were chosen based on MIC 
experiments (see Table 2). The concentrations used were expected to reduce the growth rate 
by about one-half that of the minus antibiotic control.    
Initially, wild type strain SK901 was used to assess the effect of the macrolides on the 
rates of growth and protein synthesis.  Figure 7 shows the growth of SK901 with and without 
antibiotics. 
Growth rates relative to the control were: erythromycin (46%), azithromycin (35%), and 
oleandomycin (58%).  Azithromycin  was a more effective inhibitor of growth than 
erythromycin, even at a very low concentration (2 mg/ml).  Oleandomycin was the least effective 
under these conditions.  
 Figure 8 shows the results of protein synthesis inhibition experiments in SK901 by the 
same antibiotics at the same concentrations.
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Table 2. Antibiotic Minimal Inhibitory Concentrations. 
The LC50 equals the antibiotic concentration found to give 50% inhibition of maximal 
growth. 
 
 
Strain  Antibiotic  LC50 (mg/ml)  
SK901  erythromycin     80 
SK901  azithromycin      0.5 
SK901  oleandomycin  150 
     
SK5665 erythromycin    20 
SK5665 azithromycin      0.5 
SK5665 oleandomycin  150 
           
SK1217 erythromycin    10 
SK1217 azithromycin      0.1 
SK1217 oleandomycin    50 
      
SK1219 erythromycin    20  
SK1219 azithromycin      0.5 
SK1219 oleandomycin  100 
     
MRE600 erythromycin      2 
MRE600 azithromycin      0.1 
MRE600 oleandomycin    20        
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FIGURE 7.  INHIBITION OF CELL GROWTH IN STRAIN SK901 BY MACROLIDE 
ANTIBIOTICS. 
Five ml cultures of strain SK901 were grown in Tryptone broth (T broth) in 125 ml 
side-arm flasks at 37oC for 4 hours with either no antibiotic ( ), erythromycin at 75 mg/ml ( ), 
azithromycin at 2 mg/ml  ( ), or oleandomycin at 150 mg/ml  ( ). 
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FIGURE 8. INHIBITION OF PROTEIN SYNTHESIS IN STRAIN SK901 BY 
MACROLIDE ANTIBIOTICS. 
Strain SK901 was grown in T broth containing a 35S-methionine-cysteine mixture (1 
mCi/ml) at 37oC with either no antibiotic ( ), erythromycin at 75 mg/ml ( ), azithromycin at 2 
mg/ml ( ), or oleandomycin at 150 mg/ml ( ).  Samples (0.2 ml) were removed from a 5 ml 
culture at 5 minute intervals into 1 ml of 10% TCA.  Samples were collected on GF/A filters, 
washed with 10% TCA and ethanol then the radioactivity was measured in 5 ml scintillation 
fluid.   
0
3000
6000
9000
12000
15000
18000
21000
24000
0 5 10 15
 C
PM
  I
nc
or
po
ra
te
d 
 3
5 S
-m
et
-c
ys
Time (minutes)    
 
 
Reduced rates of protein synthesis were observed in the cultures containing the 
antibiotics.   Azithromycin was the most effective inhibitor of protein synthesis. Oleandomycin 
and erythromycin had a similar effect when the concentration of oleandomycin was twice that of 
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erythromycin.  
 A summary of the antibiotic effects on SK901 is shown in Table 3. 
 
 
Table 3.  Summary of Macrolide Antibiotic Effects on Growth and Protein Synthesis Rates in 
Strain SK901. 
 
 
Antibiotic    Rate of     
Condition        Concentration Doubling Time  Protein Synthesis % of Control 
No Drug    0 mg/ml 50 minutes              1,333 CPM/minutes  100  
Erythromycin    75 mg/ml 180 minutes  654 CPM/minutes  49  
Azithromycin     2 mg/ml 400 minutes   376 CPM/minutes  28  
Oleandomycin 150 mg/ml 100 minutes  655 CPM/minutes  49  
 
 Comparison of macrolide effects on growth rate (by Klett unit reading) and protein 
synthesis (by 35S amino acid incorporation). 
 
 
 
 
 Four mutant E. coli  strains were tested for sensitivity to erythromycin.  In comparison 
to SK901, each of the mutant strains was found by previous work to be hypersensitive to 
growth inhibition by erythromycin (Held and Nomura 1973; Champney 1979; Babitzke et al. 
1993). 
 A measure of hypersensitivity was the recovery time required to resume normal growth 
after erythromycin was removed from the cell culture.  Figures 9 and 10 show growth curves for 
normal growth, inhibition by erythromycin, and erythromycin recovery in strains SK901 and 
MRE600 respectively.  
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FIGURE 9. ERYTHROMYCIN INHIBITION AND RECOVERY IN STRAIN SK901. 
Strain SK901 was grown in T broth at 37oC with no antibiotic present ( ), or with 
erythromycin at 75 mg/ml  ( ).  Recovery was assessed by starting a culture without antibiotic 
( ), then adding 75 mg/ml of erythromycin at the indicated time ( ).  After a period of growth 
inhibition, cells were collected by centrifugation, resuspended in fresh T broth ( ) and allowed 
to continue growth. 
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FIGURE 10. ERYTHROMYCIN INHIBITION AND RECOVERY IN STRAIN MRE600. 
Strain MRE600 was grown in T broth at 37oC with no antibiotic present ( ), or with 
erythromycin at 2 mg/ml  ( ).  Recovery was assessed by starting a culture without antibiotic 
( ), then adding 2 mg/ml of erythromycin at the indicated time ( ).  After a period of growth 
inhibition, cells were collected by centrifugation, resuspended in fresh T broth ( ) and allowed 
to continue growing. 
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 Strains SK1217 and SK1219 are hypersensitive to erythromycin due to a mutation in 
the gene for ribosomal protein L15 (Champney, unpublished observation).  Recovery from 
eryhtromycin inhibition in these strains is shown in Figures 11 and 12.  
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FIGURE 11. ERYTHROMYCIN INHIBITION AND RECOVERY IN STRAIN SK1217. 
Strain SK1217 was grown in T broth at 37oC with no antibiotic present ( ), or with 
erythromycin at 20 mg/ml  ( ).  Recovery was assessed by starting a culture without antibiotic 
( ), then adding 20 mg/ml of erythromycin at the indicated time ( ).  After a period of growth 
inhibition, cells were collected by centrifugation, resuspended in fresh T broth ( ) and allowed 
to continue growing. 
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FIGURE 12. ERYTHROMYCIN INHIBITION AND RECOVERY IN STRAIN SK1219. 
Strain SK1219 was grown in T broth at 37oC with no antibiotic present ( ), or with 
erythromycin at 20 mg/ml  ( ).  Recovery was assessed by starting a culture without antibiotic 
( ), then adding 20 mg/ml of erythromycin at the indicated time ( ).  After a period of growth 
inhibition, cells were collected by centrifugation, resuspended in fresh T broth ( ) and allowed 
to continue growing. 
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Finally, a temperature-sensitive RNase E mutant strain SK5665 was examined because 
RNase E has been shown to be involved in rRNA turnover (Bessarb et al. 1998).  Figure 13 
shows the results for erythromycin recovery assays in this strain. 
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FIGURE 13. ERYTHROMYCIN INHIBITION AND RECOVERY IN STRAIN SK5665. 
Strain SK5665 was grown in T broth at 37oC with no antibiotic present ( ), or with 
erythromycin at 18 mg/ml  ( ).  Recovery was assessed by starting a culture without antibiotic 
( ), then adding 18 mg/ml of erythromycin at the indicated time ( ).  After a period of growth 
inhibition, cells were collected by centrifugation, resuspended in fresh T broth ( ) and allowed 
to continue growing. 
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A summary of the recovery times for these strains is shown in Table 4. 
 
Table 4.  Summary of Inhibition Data by Erythromycin in Five E. coli  Strains. 
Recovery time was the interval required by the cultures to resume a logarithmic growth 
phase.  Strains SK1217 and SK1219 remained static. 
 
 
          
Erythromycin   Recovery   
Strain  Phenotype Concentration  Time (minutes)  
 
SK901  wild type 75 mg/ml      30  
MRE600 RNase 1-     2 mg/ml    120  
SK1217 ts L15  20 mg/ml  >450  
SK1219 ts L15  20 mg/ml  >450 
SK5665 RNase E- 18 mg/ml      45  
 
 
 
Erythromycin Uptake and Efflux Assays  
 
 The basis for erythromycin hypersensitivity in strains SK5665, SK1217 and SK1219 is 
more clearly understood than that of MRE600.  It is possible that the difference in erythromycin 
sensitivity between SK901 and MRE600 was related to the rate of erythromycin uptake or 
loss. 
In order to compare the relative rates of uptake and loss of antibiotic, experiments were 
done using 14C-erythromycin.  Uptake was measured in strains SK901 and MRE600 that were 
either growing or static.  Loss experiments were done in growing cells in these strains as 
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described.  Figure 14 shows rates of erythromycin uptake into these cells.  In  both strains, the 
first sample collected contained the most erythromycin. 
 
FIGURE 14.  UPTAKE OF  14C-ERYTHROMYCIN  INTO GROWING CELLS. 
Strains SK901 ( )  and MRE600 ( ) were grown in T broth at 37oC to equal cell 
densities.  A mixture of 15 mg/ml unlabeled erythromycin and 1.5 mg/ml (0.1 mCi/ml) of 14C-
erythromycin was added to each culture.  Samples of cells (0.2 ml) were collected at 5 minutes 
time intervals, captured on a filter, washed with S-buffer, and the radioactivity measured.   
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In an attempt to verify that the results in Figure 14 represented rapid uptake, 
erythromycin uptake experiments were repeated in SK901 using static cells that had been 
suspended in HEPES buffer for 15 minutes prior to addition of erythromycin and also by adding 
excess unlabeled carrier antibiotic as described.  Figure 15 shows the results from these assays. 
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FIGURE 15.  COMPETITION FOR  14C-ERYTHROMYCIN  BY UNLABELED 
ERYTHROMYCIN IN STATIC SK901 CELLS. 
1.5 mg/ml of 14C-erythromycin  (0.1 mCi/ml) and 15 mg/ml ( ) or 75 mg/ml ( ) 
unlabeled erythromycin were added at the same time.  In another experiment, the isotope was 
added 5 seconds after 75 mg/ml of unlabeled antibiotic ( ).  Samples of 0.2 ml were collected 
at 5 minute intervals and captured on filters as described (Figure 14). 
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Increasing the amount of unlabeled erythromycin carrier from 15 mg/ml to 75 mg/ml 
resulted in a reduced rate of antibiotic loss from the cells.  Addition of the isotope  5 seconds 
after the carrier caused the maximum uptake to be delayed by 5 minutes.  At 15 mg/ml of 
unlabeled erythromycin, maximum loss from the cells occurred in the first 5 minutes.  At 75 
mg/ml of unlabeled erythromycin, maximum loss was not seen until the 40 minute time point. 
 A possible reason for the difference in erythromycin sensitivity between SK901 and 
MRE600 was reduced rates of loss as Figure 16 shows. 
  
50
 
FIGURE 16.  LOSS OF 14C-ERYTHROMYCIN  FROM GROWING CELLS. 
Strains SK901 ( ) and MRE600 ( ) were grown to equal cell densities in the 
presence of 15 mg/ml unlabeled erythromycin and 1.5 mg/ml of 14C-erythromycin. Cells were 
pelleted by centrifugation and resuspended in antibiotic-free T broth.  Samples of 0.2 ml were 
collected at 5 minute intervals and captured on filters as described (Figure 14). 
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After being centrifuged and resuspended in fresh T broth, the cells lost about 50% of 
the intercellular antibiotic in the first 5 minutes and the remainder at a slower rate.  MRE600 had 
more erythromycin at the beginning and lost it more slowly.  Erythromycin loss in other strains 
was very similar to SK901 (data not shown).  
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Pulse-Chase Analysis of Ribosomal Subunit Assembly  
 
To see if the hypersensitivity to erythromycin in these 5 strains was reflected in 50S 
subunit assembly inhibition, a pulse-chase analysis of subunit assembly was conducted.  This 
method was used to track the fate of a discrete population of rRNA molecules that were 
synthesized during a 90-second pulse labeling period.  The rates at which the labeled rRNAs 
were assembled into ribosomal subunits were examined.  Figure 17 shows sucrose gradient 
profiles of labeled subunits from SK901 following a 45-minute chase period during growth in 
the presence and absence of erythromycin. 
After a 45-minute chase period, SK901 had incorporated most of the labeled rRNA 
into 30S and 50S subunits.  A normal 1:1 particle stoichiometry of the ribosomal subunits was 
indicated in these wild type cells by the 2:1 ratio of radioactivity in the 50S:30S peaks.  In the 
presence of erythromycin, there was a marked decrease in 50S subunit assembly and the 
50S:30S ratio fell to 0.5:1 and an additional peak sedimented into the region between the 30S 
and 50S subunit peaks.  A similar pulse-chase analysis was performed on strain MRE600 and 
the gradient profiles are shown in Figure 18.  The inhibition of 50S subunit assembly was seen in 
this RNase 1-  strain at a very low erythromycin concentration.  The peak in the 30S region was 
broader and of a lower S value compared with that of strain SK901, suggesting heterogeniety.   
In Figure 19, results are shown for the pulse-chase labeling of the L15 mutant strain 
SK1217.  The cells growing with the antibiotic present showed a highly reduced level of subunit 
assembly.  In strain SK1217 an altered 50S:30S ratio was also apparent.  
The other L15 mutant was also analyzed by the pulse-chase method and the results are 
shown in Figure 20.  In the presence of erythromycin, strain SK1219 assembled an RNA-
containing particle that sedimented between the 30S and 50S peaks.   
Finally, the pulse-chase analysis of the RNase E mutant strain SK5665 revealed a 
major reduction in 50S subunit assembly and a large peak that sedimented into the 20S-30S 
region in the erythromycin-treated culture as shown in Figure 21. 
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FIGURE 17.  SUCROSE GRADIENT PROFILE OF SUBUNITS FROM STRAIN SK901 
GROWN WITH AND WITHOUT ERYTHROMYCIN. 
Strain SK901 was grown at 37oC in T broth either with no antibiotic ( ) or with 
erythromycin at 75 mg/ml ( ).  The samples were pulse-labeled and chased for 45 minutes.  
Cell lysates were separated by centrifugation and the 3H-uridine CPM in gradient fractions was 
measured. 
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FIGURE 18. SUCROSE GRADIENT PROFILE OF SUBUNITS FROM STRAIN 
MRE600 GROWN WITH AND WITHOUT ERYTHROMYCIN. 
Strain MRE600 was grown at 37oC in T broth either with no antibiotic ( ) or with 
erythromycin at 2 mg/ml.  The samples were pulse-labeled and chased for 45 minutes.  Cell 
lysates were separated by centrifugation and the 3H-uridine CPM in gradient fractions was 
measured. 
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FIGURE 19. SUCROSE GRADIENT PROFILE OF SUBUNITS FROM STRAIN SK1217 
GROWN WITH AND WITHOUT ERYTHROMYCIN. 
Strain SK1217 was grown at 37oC in T broth either with no antibiotic ( ) or with 
erythromycin at 20 mg/ml ( ). The samples were pulse-labeled and chased for 45 minutes.  Cell 
lysates were separated by centrifugation and the 3H-uridine CPM in gradient fractions was 
measured. 
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FIGURE 20. SUCROSE GRADIENT PROFILE OF SUBUNITS FROM STRAIN SK1219 
GROWN WITH AND WITHOUT ERYTHROMYCIN. 
Strain SK1219 was grown at 37oC in T broth either with no antibiotic ( ) or with 
erythromycin at 20 mg/ml ( ).  The samples were pulse-labeled and chased for 45 minutes.  
Cell lysates were separated by centrifugation and the 3H-uridine CPM in gradient fractions was 
measured. 
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FIGURE 21. SUCROSE GRADIENT PROFILE OF SUBUNITS FROM STRAIN SK5665 
GROWN WITH AND WITHOUT ERYTHROMYCIN. 
Strain SK5665 was grown at 37oC in T broth either with no antibiotic ( ) or with 
erythromycin at 18 mg/ml ( ).  The samples were pulse-labeled and chased for 45 minutes.  
Cell lysates were separated by centrifugation and the 3H-uridine CPM in gradient fractions was 
measured. 
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Assembly of the 50S subunit was inhibited and a double peak was seen in the 25-30S 
region of the gradient.  In the absence of RNase E, there was a greater build up of precursor 
particle than was seen in the other strains. 
 A summary of the pulse-chase assembly data for the wild type and 4 mutant strains is 
shown in Table 5. 
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Table 5.  Summary of Pulse-Chase Assembly Data in Five E. coli  Strains. 
 
 
      % Total  
Gradient CPM Ratio of  50S Subunit 
Strain  Phenotype [Erythromycin]   30S 50S 50S/30S  Reduction 
SK901  wild type   0 mg/ml  12.3 17.4 1.4  
SK901  wild type 75 mg/ml  15.4   4.7 0.3  73% 
 
MRE600  RNase 1-   0 mg/ml  16.5 28.2 1.7 
MRE600  RNase 1-   2 mg/ml  12.0   3.1 0.3  89% 
 
SK1217  ts L15    0 mg/ml    8.5 10.3 1.2 
SK1217  ts L15  20 mg/ml    7.0   4.3 0.6  58% 
   
SK1219  ts L15    0 mg/ml  10.7 14.1 1.3 
SK1219  ts L15  20 mg/ml  13.3   5.1 0.4  63% 
 
SK5665  RNase E-   0 mg/ml  20.4 30.0 1.5  
SK5665  RNase E- 18 mg/ml  26.4 10.7 0.4  64% 
 
 
 
 
Note that in Table 5, the 30S assembly is about the same, with and without 
erythromycin, in each strain. On the other hand, 50S assembly with erythromycin present was 
reduced by 50-80%.  Thus suggests a specific effect of erythromycin on 50S subunit formation 
both in wild type cells and in the mutant cells examined. 
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 Dynamics of Ribosomal Subunit Formation and Assembly Kinetics 
 
 Because of the suggested involvement of RNase E in ribosomal subunit turnover 
(Bessarab 1998), strains SK901 and SK5665 were chosen to characterize the dynamics of 
subunit formation that occurs in the presence and absence of erythromycin.  Pulse-chase assays 
were performed at 37oC and samples were harvested at intervals of 1.5, 3, 7.5, 15, 30, and 45 
minutes after the pulse of 3H-uridine.  Lysates were fractionated by centrifugation as described.   
 A second series of pulse-chase experiments were conducted at 27oC to slow the 
growth rate and subunit assembly time which has been shown to be proportional to the growth 
rate in E. coli  (Lindahl 1975). 
The percent of RNA in different gradient peaks from the SK901 and SK5665 pulse-
chase experiments was determined by dividing the sum of the counts in each peak by the total 
number of counts in that gradient.  These percentages were plotted against time to obtain the 
kinetic profiles for ribosomal subunit formation in the control and erythromycin-treated samples 
at 27oC and 37oC.   
 Figure 22 A-F is a composite of twelve pulse-chase assays showing 30S and 50S 
subunit assembly in SK901 at 37oC growing with and without erythromycin.   
In the cells containing erythromycin, 50S subunit assembly was suppressed in the 1.5 
and 3 minute samples (Figure 22 A and B).  At the 7.5 minute time point (Figure 22 C),  an 
RNA-containing particle had sedimented into the area between the 30S and 50S gradient 
regions.  At the 15 and 30 minute time points (Figure 22 D and E), this intermediate precursor is 
seen between the 30S and 50S gradient regions of the erythromycin-treated samples.  At the 45 
minute time point (Figure 22 F), 3 distinct peaks are seen in the antibiotic treated sample.  
The kinetics of the assembly process can best be observed in 3 dimensions. Dynamic 
profiles of these pulse-chase assays were constructed using the data from each chase period 
and are shown in Figure 23.  Changes in color on the graphs are representative of change in 3H-
uridine radioactivity on the Y axis.  
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FIGURE 22. GRADIENT PROFILES OF RIBOSOMAL SUBUNITS FROM STRAIN 
SK901 PULSE-CHASE ANALYSIS. 
SK901 was grown at 37oC in T broth either with no antibiotic ( ) or with erythromycin 
at 75 mg/ml ( ), and were pulse-labeled and chased as described.  Samples were taken at 1.5 
minute (A), 3 minute (B), 7.5 minute (C), 15 minute (D), 30 minute (E), and 45 minute (F) 
chase times. 
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FIGURE 23.  STRAIN SK901 PULSE-CHASE GRADIENT COMPOSITE AT 37oC. 
 Strain SK901 was grown at 37oC in T broth either with no antibiotic (A) or with 
erythromycin at 75 mg/ml (B).  Sucrose gradient profiles like those in Figure 22 were 
superimposed in this composite figure. 
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The cells grown without erythromycin (Figure 23 A) showed normal assembly of 30S 
and 50S subunit particles over time.  In the presence of erythromycin at 75 mg/ml (Figure 23 B), 
a reduced 50S peak was observed and an intermediate density particle accumulated in the 40S 
region.  The kinetics of these assembly processes are shown in Figure 24.  In the SK901 culture 
grown at 37oC without antibiotic (Figure 24 A), assembly of the 30S subunit  was complete by 
7.5 minutes.  The 50S subunit assembly was completed by 15 minutes.  In the presence of 
erythromycin (Figure 24 B), 50S subunit assembly was suppressed but 30S subunit assembly 
appeared to be unaffected. 
At the reduced temperature (27oC), SK901 subunit assembly was slowed in both the 
without antibiotic (Figure 25 A) and the erythromycin-treated (Figure 25 B) cultures.   
The kinetics of these subunit assembly processes at the reduced temperature are shown in 
Figure 26.  In the SK901 27oC sample without antibiotic (Figure 26 A), assembly of the 30S 
subunit  was again completed by 7.5 minutes.  The 50S subunit assembly was completed by 
about 30 minutes.  In the presence of erythromycin (Figure 26 B), 50S subunit assembly was 
suppressed but 30S subunit assembly seemed unaffected.   
In Figure 27, the results of subunit assembly in SK5665 are shown.  The SK5665 cells 
grown without antibiotic (Figure 27 A) showed a normal assembly sequence of 30S and 50S 
subunit particles over time.  The accumulation of large amounts of RNA containing particle(s) in 
the 20-30S region of the erythromycin treated sample (Figure 27 B) was apparent.  The 
kinetics of this assembly process at 37oC are shown in Figure 28.  In the SK5665 37oC no 
antibiotic sample (Figure 28 A), assembly of the 30S subunit was completed by 7.5 minutes.  
The 50S subunit assembly was completed by 30 minutes.  In the presence of erythromycin 
(Figure 28 B), 50S subunit assembly is extremely suppressed while 30S subunit assembly was 
completed by about 30 minutes.   
Finally, pulse-chase analysis was repeated in SK5665 at 27oC.  At the reduced 
temperature, SK5665 subunit assembly was slowed in cells grown without antibiotic (Figure 29 
A).  In the erythromycin treated sample (Figure 29 B), the increased peak is again seen in the 
25S-30S region.  The kinetics of this assembly process at the reduced temperature are shown 
in Figure 30. 
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FIGURE 24.  RIBOSOMAL SUBUNIT ASSEMBLY KINETICS IN SK901 AT 37OC. 
Gradient CPM in the 30S and 50S regions from Figure 23 expressed as a percent of 
the total CPM.   Part A shows assembly of the 30S subunits ( ) and 50S subunits ( ) of cells 
grown without antibiotic.  Part B shows the 30S subunits ( ) and 50S subunits ( ) of cells 
grown in the presence of erythromycin at 75 mg/ml. 
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FIGURE 25. STRAIN SK901 PULSE-CHASE GRADIENT COMPOSITE AT 27oC. 
Strain SK901 was grown at 27oC in T broth either with no antibiotic (A) or with 
erythromycin at 75 mg/ml (B).  Sucrose gradient profiles like those in Figure 22 were 
superimposed in this composite figure. 
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FIGURE 26.  RIBOSOMAL SUBUNIT ASSEMBLY KINETICS IN SK901 AT 27OC. 
Gradient CPM in the 30S and 50S regions from Figure 25 expressed as a percent of 
the total CPM.   Part A shows assembly of the 30S subunits ( ) and 50S subunits ( ) of cells 
grown without antibiotic.  Part B shows the 30S subunits ( ) and 50S subunits ( ) of cells 
grown in the presence of erythromycin at 75 mg/ml. 
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FIGURE 27.  SK5665 PULSE-CHASE COMPOSITE AT 37oC. 
Strain SK5665 was grown at 37oC in T broth either with no antibiotic (A) or with 
erythromycin at 18 mg/ml (B).  Sucrose gradient profiles like those in Figure 22 were 
superimposed in this composite figure. 
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FIGURE 28.  RIBOSOMAL SUBUNIT ASSEMBLY KINETICS IN SK5665 AT 37OC.  
Gradient CPM in the 30S and 50S regions from Figure 27 expressed as a percent of 
the total CPM.   Part A shows assembly of the 30S subunits ( ) and 50S subunits ( ) of cells 
grown without antibiotic.  Part B shows the 30S subunits ( ) and 50S subunits ( ) of cells 
grown in the presence of erythromycin at 18 mg/ml. 
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FIGURE 29.  SK5665 PULSE-CHASE COMPOSITE AT 27oC. 
 Strain SK5665 was grown at 27oC in T broth either with no antibiotic (A) or with 
erythromycin at 18 mg/ml (B).  Sucrose gradient profiles like those in Figure 22 were 
superimposed in this composite figure. 
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FIGURE 30.  RIBOSOMAL SUBUNIT ASSEMBLY KINETICS IN SK5665 AT 27OC. 
Gradient CPM in the 30S and 50S regions from Figure 29 expressed as a percent of 
the total CPM.   Part A shows assembly of the 30S subunits ( ) and 50S subunits ( ) of cells 
grown without antibiotic.  Part B shows the 30S subunits ( ) and 50S subunits ( ) of cells 
grown in the presence of erythromycin at 18 mg/ml. 
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In the SK5665 27oC no antibiotic sample (Figure 30 A), assembly of the 30S subunit 
was completed by 15 minutes.  The 50S subunit assembly was completed by 30 minutes.  In 
the presence of erythromycin (Figure 30 B), 50S subunit assembly was suppressed but 30S 
subunit assembly was unaffected. 
Growth of strains SK901 and SK5665 at 27oC slowed the growth rate and increased 
the time required for assembly and decay of ribosomal subunits and their intermediates.  This 
provided better conditions for isolation of precursor particles from gradient pools.  Table 6 
shows a summary of the data from these experiments. 
 
Table 6.  Temperature Effects on Growth and Subunit Assembly in SK901 and SK5665. 
 
        
       Total Gradient   % Reduction 
   Erythromycin Doubling % CPM after 50S:30S  in 50S Subunit 
Strain  Temp. Concentration  Time  30S 50S Ratio  Assembly  
SK901  37oC   0 mg/ml 45 min.  6.6 14.3 2.2  --- 
SK901  37oC 75 mg/ml 360 min.  6.9 5.8 0.8  60 ± 8.6 
SK901  27oC   0 mg/ml  90 min.  5.8 6.0 1.0  --- 
SK901  27oC 75 mg/ml >480 min.  6.2 2.6 0.4  56 ± 8.7 
 
SK5665 37oC   0 mg/ml 90 min.  11.1 11.9 1.0  --- 
SK5665 37oC 18 mg/ml >480 min.  13.0 2.5 0.2  78 ± 4.7 
SK5665 27oC   0 mg/ml 100 min.  9.4 7.3 0.8  --- 
SK5665 27oC 18 mg/ml >480 min.  11.3 2.7 0.2  63 ± 6.3 
 
 
 
At the reduced temperature, cell doubling times increased and the assembly of 
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ribosomal subunits was slowed.  The decreased 50S:30S subunit ratio that occurred in the 
presence of erythromycin was more pronounced at the reduced temperature in strain SK901.  
Strain SK5665 was severely inhibited in growth and subunit assembly at both temperatures. 
The pulse-chase experiments on both strains showed a clear inhibition of 50S formation 
and indicated a possible precursor in the 30S region of the gradients (Figures 23 B, 25 B, 27 B, 
and 29 B).  The rRNA and the protein content of these gradient fractions were examined to 
look for 23S and 5S rRNA species and 50S subunit proteins. 
 
RNA Analysis 
 
Cells of both strains were grown at 27oC in the presence of 3H uridine, and subunits 
were separated by sucrose gradient centrifugation as described.  RNA was isolated from each 
fraction and separated by electrophoresis.  The gels were dried and radioactivity in the RNA 
was examined by fluorography. 
Polyacrylamide gel electrophoresis was used to determine the rRNA content of the 
ribosomal subunit particles assembled both without antibiotic and in the presence of 
erythromycin.  A dual concentration of polyacrylamide was used to separate RNA from 
gradient fractions 11-30.  The top one-third of each gel contained 4% polyacrylamide to 
separate the 16S and 23S rRNAs.  The bottom two thirds of each gel contained 7% 
polyacrylamide to retard the 5S rRNA and small oligonucleotides.  
  Figure 31 shows the results from SK901 cells grown without antibiotic.  The 16S 
rRNA was found in the 30S gradient region and 23S rRNA in the 50S region as expected.  
Fractions 20-22 did not contain appreciable amounts of RNA. 
Figure 32 shows the results from SK901 cells grown in the presence of erythromycin at 
75 mg/ml.  16S rRNA was found in the 30S region, but in fractions 17-22, 23S rRNA was 
seen also.  A small amount of 5S rRNA was also seen in this region.  23S rRNA was found in 
the 50S region (fractions 24-28) as expected.  In contrast to the without antibiotic samples, 
fractions 20-22 also contained dual RNA bands.  
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FIGURE 31.  RNA FLUOROGRAM FROM SK901 CONTROL CELLS.  
Gradient fractions from SK901 cells labeled with 3H-uridine for 30 minutes were 
separated by electrophoresis on a 4%/7% polyacrylamide gel.  The fluorogram was exposed to 
X-ray film at -80oC for 3 weeks.   
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Breakdown products of rRNA in control and erythromycin-treated cells were studied 
by examining small oligoribonucleotides that accumulated in the upper sucrose gradients fraction 
(1-10).  Figure 33 shows the results from SK901 cells with and without erythromycin.  
Fractions from cells grown with erythromycin (75 mg/ml) contained a large amount of small or 
broken RNA fragments relative to fractions from cells grown in the absence of antibiotic. 
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FIGURE 32. RNA FLUOROGRAM FROM SK901 CELLS GROWN WITH 
ERYTHROMYCIN. 
Gradient fractions from SK901 cells grown with erythromycin (75 mg/ml) and labeled 
with 3H-uridine for 30 minutes were separated by electrophoresis on a 4%/7% polyacrylamide 
gel.  The fluorogram was exposed to X-ray film at -80oC for 3 weeks. 
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 Figure 34 shows the 16S rRNA that was found in the 30S gradient region along with 
RNA that migrated to the gel interface.  The 23S and 5S rRNAs were seen in the 50S region as 
expected.  Fractions 20-22 contained RNA that was trapped at the gel interface. 
Figure 35 shows the results from SK5665 cells grown with erythromycin (18 mg/ml).  
Very little 23S rRNA was found in particles dense enough to sediment into the 50S gradient 
region.  
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FIGURE 33. RNA FLUOROGRAM FROM SK901 CELLS GROWN WITH AND 
WITHOUT ERYTHROMYCIN FRACTIONS 1-10.  
Top gradient fractions from SK901 cells grown with erythromycin (75 mg/ml) or 
without erythromycin were 3H-uridine labeled and the RNA was separated by electrophoresis 
on a 7% polyacrylamide gel.  The fluorogram was exposed to X-ray film at -80oC for 3 weeks. 
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Small oligoribonucleotides that accumulated in the upper sucrose gradients fraction (1-
10) were examined in SK5665.  Figure 36 shows the results using cells grown with and without 
erythromycin.  Fractions from cells grown with erythromycin (18 mg/ml) contained a large 
amount of small or broken RNA fragments relative to the without antibiotic cultures. A more 
extensive accumulation of RNA fragments was found in SK5665 compared with SK901 as 
figure 36 shows (compare with Figure 33).  This suggests reduced turnover of rRNA in the 
RNase E- strain. 
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FIGURE 34.  FLUOROGRAM OF RNA FROM SK5665 CONTROL CELLS. 
Gradient fractions from SK5665 cells labeled with 3H-uridine for 30 minutes were 
separated by electrophoresis on a 4%/7% polyacrylamide gel.  The fluorogram was exposed to 
X-ray film at -80oC for 3 weeks. 
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A more specific identification of rRNA in the particles was performed by northern 
blotting and hybridization with a 23S rRNA-specific DNA probe.  Figure 37 shows a 
comparison of  slot blots done on rRNA from SK901 cells grown with and without 
erythromycin at 75 mg/ml.  The gradient fractions from cells grown with erythromycin (front) 
contained most of their 23S rRNA in the 50S region.  In comparison, the fractions from cells 
grown with erythromycin (rear) had 23S rRNA in the 30S-40S as well as the 50S gradient 
region. 
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FIGURE 35. RNA FLUOROGRAM FROM SK5665 CELLS GROWN WITH 
ERYTHROMYCIN. 
Gradient fractions from SK5665 cells grown with erythromycin (18 mg/ml) and labeled 
with 3H-uridine for 30 minutes were separated by electrophoresis on a 4%/7% polyacrylamide 
gel.  The fluorogram was exposed to X-ray film at -80oC for 3 weeks. 
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FIGURE 36. RNA FLUOROGRAM FROM SK5665 CELLS GROWN WITH AND 
WITHOUT ERYTHROMYCIN FRACTIONS 1-10.   
Top gradient fractions from SK5665 cells grown with erythromycin (18 mg/ml) or 
without erythromycin were 3H-uridine labeled and the RNA was separated by electrophoresis 
on a 7% polyacrylamide gel.  The fluorogram was exposed to X-ray film at -80oC for 3 weeks. 
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FIGURE 37.  THE 23S rRNA CONTENT OF GRADIENT FRACTIONS FROM SK901 
CELLS GROWN WITH AND WITHOUT ERYTHROMYCIN.  
Northern hybridization to slot blots of RNA from gradient fractions of antibiotic free 
(front) and erythromycin-treated (rear) cells.  RNA from gradient fractions was collected on a 
nylon membrane and hybridized with a biotinylated 146 bp DNA probe specific for 23S rRNA.  
X-ray film images (1 hour exposure) were captured by an Alpha Innotec imaging system and 
integrated to give optical density units.  
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Slot blots were also done on SK5665 from with erythromycin (18 mg/ml) and no 
antibiotic gradient fractions (27oC in T broth) and are shown in Figure 38.  Hybridization to a 
23S specific probe was determined by optical densitometry scanning analysis of slot blot films.  
Compared to the SK901 cultures, the SK5665 no antibiotic fractions (front) contained less 23S 
rRNA in the 50S region.  The erythromycin treated fractions (rear) had a similar peak of 23S 
rRNA in the 30S-40S as well as the 50S gradient region.
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FIGURE 38. THE 23S rRNA CONTENT OF GRADIENT FRACTIONS FROM SK5665 
CELLS GROWN WITH AND WITHOUT ERYTHROMYCIN. 
Northern hybridization to slot blots of RNA from gradient fractions of antibiotic free 
(front) and erythromycin-treated (rear) cells.  RNA from gradient fractions was collected on a 
nylon membrane and hybridized with a biotinylated 146 bp DNA probe specific for 23S rRNA.  
X-ray film images (1 hour exposure) were captured by an Alpha Innotec imaging system and 
integrated to give optical density units.  
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Protein Analysis 
 
The identification of 23S and 5S rRNA in precursor particles that sedimented into the 
30S region lead to an examination of the 50S proteins in these particles.  Two-dimensional gel 
electrophoresis assays were used to discover the protein compositions of the 50S precursor 
particles that accumulated in the 30S gradient region in the presence of erythromycin in both 
  
79
strains.  First, isolated 30S and 50S proteins were electrophoresed separately to identify each 
of the small and large subunit proteins and to determine their relative migrations under our gel 
conditions.  In the absence of erythromycin, 30S proteins S1-S21 were found in the gels of the 
30S region and L1-L30 were found in the gels of the 50S regions of both strains. 
 Figures 39 and 40 show gels from strain SK901 grown with and without antibiotic 
present.  Proteins L1-L30 from the 50S peak and S1-S21 from the 30S peak were identified.  
Under these conditions, the 50S precursor proteins are not apparent in the 30S pool from the 
erythromycin treated culture (Figure 40).  In order to determine the protein composition of the 
50S precursors that accumulated in the presence of erythromycin, cells were grown in minimal 
media at 27oC with a 35S-methionine-cysteine mixture with and without erythromycin.  Cells 
were lysed and their contents separated by sucrose gradient centrifugation as described.  
Fractions corresponding to the 30S and 50S gradient regions were pooled and each pool was 
mixed with unlabeled 70S carrier ribosomes.  Proteins from each of the fraction pools were 
extracted and separated by 2-D gel electrophoresis.  Individual spots were cut from each gel, 
the polyacrylamide dissolved and the amount of isotope in each gel spot was quantitated by 
liquid scintillation counting. 
In the absence of erythromycin, 30S proteins S1-S21 were found in the gels of the 30S 
region along with small amounts of some 50S proteins.  The 50S gradient regions showed only 
50S proteins under these same conditions.  In the presence of erythromycin, a reduced amount 
of 50S proteins were found in the 50S gradient region and more 50S proteins were found in the 
30S gradient pool gels.  The protein composition of the 50S precursors was determined by 
subtracting the amount of 50S proteins that were localized in the 30S pools of cells grown in the 
absence of erythromycin from the 50S proteins in the 30S pools from cells grown with 
erythromycin.  Results from these experiments using strain SK901 (Figure 41) and strain 
SK5665 (Figure 42) are shown.
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FIGURE 39.  TWO-DIMENSIONAL POLYACRYLAMIDE GELS 0F PROTEINS FROM 
SK901 CELLS GROWN WITHOUT ERYTHROMYCIN. 
 Gradient fractions from the 30S and 50S peaks of antibiotic-free (ND) cultures grown 
in T broth at 37oC  were pooled separately and the proteins were isolated.  50S proteins L1-
L30 (top) and 30S proteins S1-S21 (bottom) are shown.  
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FIGURE 40. TWO-DIMENSIONAL POLYACRYLAMIDE GELS 0F PROTEINS FROM 
SK901 CELLS GROWN WITH ERYTHROMYCIN. 
 Cells grown in T broth at 37oC with erythromycin (+ERY) were lysed and fractionated.  
The proteins were isolated from gradient pools.  50S proteins L1-L30 (top) and 30S proteins 
S1-S21 (bottom) are shown. 
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FIGURE 41.  PROTEIN COMPOSITION OF THE 50S PRECURSORS THAT 
ACCUMULATED IN STRAIN SK901 IN THE PRESENCE OF ERYTHROMYCIN. 
With the background subtracted, there were specific 50S proteins found in pooled 30S 
gradient fractions of SK901 cells that were labeled with 35S-methionine-cysteine in the presence 
of erythromycin at 75 mg/ml.  The number of CPM per number of sulfur containing protein 
residues was determined for each gel.  Bar heights indicate the number of labeled amino acid 
residues recovered from each gel spot.  The 35S-CPM were normalized to 30S proteins S8 (six 
sulfur containing amino acid residues) and S10 (two sulfur containing amino acid residues) (Giri 
et al. 1984). 
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FIGURE 42.  PROTEIN COMPOSITION OF THE 50S PRECURSORS THAT 
ACCUMULATED IN STRAIN SK5665 IN THE PRESENCE OF ERYTHROMYCIN. 
With the background subtracted, there were specific 50S proteins found in pooled 30S 
gradient fractions of SK5665 cells that were labeled with 35S-methionine-cysteine in the 
presence of erythromycin at 18 mg/ml.  The number of CPM per number of sulfur containing 
protein residues was determined for each gel.  Bar heights indicate the number of labeled amino 
acid residues recovered from each gel spot.  The 35S-CPM were normalized to 30S proteins 
S8 (six sulfur containing amino acid residues) and S10 (two sulfur containing amino acid 
residues) (Giri et al. 1984). 
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The summary presented in Table 7 compares the newly identified 50S subunit precursor 
protein content with the proteins found in two in vivo 50S assembly intermediates and an in vitro 
50S reconstitution intermediate. 
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Table 7.  Protein Compositions of 50S Ribosomal Subunit Precursors. 
 
 
               
  In Vivo            In Vitro   
 
     +ERY 50S Intermediate Precursor      Reconstitution 
Protein  SK901   SK5665  p
1
50S  p
2
50S  RI50(1)   
 
L1    +    +    +    +    + 
L2    ?    ?    -     -    ± 
L3    -    +    +    +    + 
L4    +    +    +    +    + 
L5    +    +    +    +    + 
L6    -    +     -     -     - 
L7/12    +    +    ±    +    + 
L9    +    +    +    +    + 
L10    +    +    +    +    + 
L11    +    +    ±    +    + 
L13    ±    +    +    +    ± 
L14    ±    +     -    +     - 
L15    +*    +*     -    +    + 
L16    -    ±     -     -     - 
L17    -    +    +    +    + 
L18    -    -    +    +    ± 
L19    -    -    -    +     - 
L20    -    -    +    +    + 
L21    -    -    +    +    + 
L22    ±    +    +    +    + 
L23    -    ±    +    +    + 
L24    -    +    +    +    + 
L25    ±    +    +    +     - 
L26    -    -    +    +     - 
L27    -    -    +    +     - 
L28    -    -    -     -    + 
L29    -    ±    +    +     - 
L30    -    -    +    +     - 
L31    ?    ?    -     -     - 
L32    ?    ?    -     -     - 
 Proteins were either present (+), present in reduced amounts (±), absent (-) or not 
determined (?).  Protein L15 (+*) was present in both 50S precursors from erythromycin 
treated cells. 
 
Adapted from Traub et al. 1971; Nierhaus 1973. 
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The protein composition of the stalled 50S assembly intermediate in strain SK901 was 
different than strain SK5665.  Proteins L6, L17, and L24 were present in SK5665 but not 
found in SK901.  Both of the stalled 50S assembly intermediates had a different protein 
composition than either the p150S (32S) or the p250S (42S) in vivo assembly intermediate 
particles that were identified by Nierhaus (1982) (see page 15).  Proteins L20, L21, L26, L27 
and L30 were present in both the in vivo assembly intermediate particles but were found in 
neither of the stalled 50S subunit assembly intermediates that accumulated in cells that were 
grown in the presence of erythromycin.  Proteins L20, L21 and L28 were present in the first in 
vitro reconstitution intermediate but not in either of the stalled 50S assembly intermediates (see 
Figure 2).     
 
 
Erythromycin Binding In Vivo 
 
 It was hypothesized that erythromycin associated with the 50S precursor particle to 
prevent assembly.  This was tested directly by 14C-erythromycin  binding experiments in 
growing cells.  These were combined with 3H-uridine pulse-chase labeling to allow quantitation 
of 50S subunit assembly defects.  In one set of experiments, ribosomal subunits were labeled by 
growing SK901 and SK5665 cells in the presence of 3H-uridine. 14C-erythromycin  at 18 mg/ml 
was added to each strain and growth was continued for two population doublings.  Cells were 
lysed, fractionated by sucrose gradient centrifugation, and the amount of each isotope present 
was determined for each gradient fraction.  Both SK901 (Figure 43 A) and SK5665 (Figure 43 
B) showed nearly normal 50S:30S ratios of steady-state labeled ribosomal subunits.  14C-
erythromycin  was found in the 50S gradient regions as expected.  However, there was another 
14C-erythromycin  peak in the areas of the 30S subunits. 
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FIGURE 43.  SUCROSE GRADIENT PROFILES OF SK901 AND SK5665 CELLS 
GROWN WITH 14C-ERYTHROMYCIN AND 3H-URIDINE AT 27oC. 
 Strains SK901(A) and SK5665 (B) showing 3H uridine steady-state labeled ribosomal 
subunits ( ) and 14C-erythromycin ( ) bound to gradient fractions.  The isotopes in the dual 
labeled gradient samples were measured separately by liquid scintillation counting. 
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To assess erythromycin binding over the course of a 45 minute chase period, pulse-
chase experiments were done using both 3H-uridine and 14C-erythromycin at 18 mg/ml in strains 
SK901 and SK5665 grown in T broth at 27oC.   Figure 44 shows the results from strain 
SK901. 
The 3H-uridine content (Figure 44 A) of each fraction showed a heterogenous particle 
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that formed in the 30S region over time.  Increasing amounts of 14C-erythromycin  (Figure 44 
B) were bound to those same gradient fractions. 
In strain  SK5665, most of the 3H-uridine labeled rRNA (Figure 45 A) made during the 
pulse was found in particles that did not sediment beyond the 20-30S region.   An erythromycin 
binding peak (Figure 45 B) was also found in the same fractions from the 20-30S region of 
these gradients.  
The effect of changes in erythromycin concentrations was also examined.  Pulse-labeling 
experiments using a 30-minute pulse time were used to assess the effect of increasing 
concentrations of erythromycin on 50S subunit assembly and on erythromycin binding to 50S 
subunits and 50S subunit precursors.  These were done using 12, 18, and 24 mg/ml of 14C-
erythromycin in strains SK901 and SK5665 grown in T broth at 27OC.   
Figure 46 shows that higher concentrations of erythromycin were associated with 
increased buildup of RNA containing particles (Figure 46 A) in the 30S gradient region of strain 
SK901 (Figure 46 A).  The proportion of 14C-erythromycin counts (Figure 46 B) bound to the 
30S region also increased at higher erythromycin concentrations. 
Figure 47 shows the results of similar experiments using SK5665.  This strain was 
severely inhibited at the highest erythromycin concentration.  3H-uridine counts (Figure 47 A) 
showed that nearly all the rRNA was incorporated into particles that did not sediment beyond 
the 30S region.  Again, binding of 14C-erythromycin  (Figure 47 B) was seen in fractions from 
the 30S gradient region. 
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FIGURE 44.  STRAIN SK901 COMPOSITE SUCROSE GRADIENT PROFILES OF 3H-
URIDINE AND 14C-ERYTHROMYCIN BINDING OVER TIME. 
Strain SK901 3H-uridine pulse-chase labeled ribosomal subunits (A) and counts per 
minute bound of 14C-erythromycin (B) from the same gadient fractions.  Sucrose gradient 
profiles like those in Figure 22 were superimposed in this composite figure. 
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FIGURE 45. STRAIN SK5665 COMPOSITE SUCROSE GRADIENT PROFILES OF 3H-
URIDINE AND 14C-ERYTHROMYCIN BINDING OVER TIME. 
Strain SK5665 3H-uridine pulse-chase labeled subunits (A) and bound  14C-
erythromycin  (B).  Sucrose gradient profiles like those in Figure 22 were superimposed in this 
composite figure. 
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FIGURE 46.  COMPOSITE OF SK901 PULSE-CHASE VS. ERYTHROMYCIN 
CONCENTRATION. 
Sucrose gradient profiles of strain SK901 3H uridine pulse-chase labeled subunits (A) 
and bound  14C-erythromycin (B).  Sucrose gradient profiles like those in Figure 22 were 
superimposed in this composite figure. 
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FIGURE 47. COMPOSITE OF SK5665 PULSE-CHASE VS. ERYTHROMYCIN 
CONCENTRATION. 
 Sucrose gradient profiles of strain SK5665 3H-uridine pulse-chase labeled subunits (A) 
and bound  14C-erythromycin (B) counts per minute found in the same gradient fractions.  
Sucrose gradient profiles like those in Figure 22 were superimposed in this composite figure. 
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 The data on erythromycin binding are correlated with the effects on 50S assembly (as 
3H uridine incorporation) in Table 8. 
 
 
Table 8.  Summary of 14C-Erythromycin Binding In vivo vs. Time. 
 
 
% of Total 
      pmol  3H uridine 
    Gradient Bound      CPM    50S/30S 
Strain  Time  Region  ERY   30S 50S Ratio  
SK901  15 min. 30S  213  18.3 --- --- 
SK901  30 min. 30S  226 ± 20 20.1 --- --- 
SK901  45 min. 30S  462  21.5 --- --- 
 
SK901  15 min. 50S  346  ---   9.9 0.54 
SK901  30 min. 50S  332 ± 28 --- 13.7 0.68 
SK901  45 min. 50S  656  --- 15.2 0.71 
 
SK5665 15 min. 30S  248  22.5 --- --- 
SK5665 30 min. 30S  249 ± 33 25.8 --- --- 
SK5665 45 min. 30S  221  25.4 --- --- 
 
SK5665 15 min. 50S  243  --- 4.7 0.21 
SK5665 30 min. 50S  287 ± 13 --- 6.6 0.26 
SK5665 45 min. 50S  340  --- 7.6 0.29 
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The influence of antibiotic concentration in both strains is shown in Table 9. 
 
 
Table 9.  Summary of 14C-Erythromycin Binding In Vivo vs. Erythromycin Concentration. 
 
            
        % of Total 
 pmol           3H-uridine  
Gradient  Bound      CPM      50S/30S 
Strain  Erythromycin Region  ERY  30S 50S Ratio  
SK901  12 mg/ml 30S  512  15.4 --- --- 
SK901  18 mg/ml 30S  799  17.2 --- --- 
SK901  24 mg/ml 30S  1,203  19.1 --- --- 
 
SK901  12 mg/ml 50S  1,496  --- 13.8 0.9 
SK901  18 mg/ml 50S  1,880  --- 10.3 0.6 
SK901  24 mg/ml 50S  1,678  --- 7.7 0.4 
 
SK5665 12 mg/ml 30S  325  14.4 --- --- 
SK5665 18 mg/ml 30S  213  15.5 --- --- 
SK5665 24 mg/ml 30S  254  18.5 --- --- 
 
SK5665 12 mg/ml 50S  725  --- 6.0 0.4 
SK5665 18 mg/ml 50S  532  --- 2.0 0.1 
SK5665 24 mg/ml 50S  246  --- 0.9 0.05 
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Because of possible degradation of 23S rRNA in the 30S gradient region that might 
cause it to migrate in the gels along with 16S rRNA, 5S rRNA was used to more accurately 
quantitate the amounts of 50S precursor in the 30S gradient regions.  
5S rRNA amounts were quantitated by densitometry scanning using a standard curve of 
known amounts run on a 7% polyacrylamide gel.  These amounts were used to calculate 50S 
precursors and 50S subunits in gradient fractions and these results were compared with 
erythromycin binding in the same fractions.  
 Cells grown with 14C-erythromycin  [18mg/ml] were gradient fractionated as described.  
Half of each fraction was separated by electrophoresis and the amount of 5S rRNA in each 
fraction was quantitated.  The amount of isotope in the remaining half of each fraction was 
determined by liquid scintillation counting.  Results of these experiments are shown in Table 10.  
Both strains contained 5S rRNA in the 30S gradient region.  Erythromycin bound to 5S rRNA 
containing particles in both the 30S gradient region and in the 50S region with an approximate 
1:1 stoichiometry. 
 
Table 10.  5S rRNA vs. 14C-Erythromycin Binding Stoichiometry. 
 
 
 
  Gradient pmol  pmol Bound Ratio of 
Strain  Region  5S rRNA 14C ERY ERY / 5S rRNA  
SK901  30S  150  190  1.2  
SK901  50S  216  187  0.8  
SK5665 30S  212  242  1.1  
SK5665 50S  211  248  1.2   
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Erythromycin Binding In Vitro 
 
Erythromycin binding to the 50S subunit precursor was compared to erythromycin 
binding to isolated 50S subunits to further test the binding stoichiometry.   The stoichiometry 
was measured by standard curves relating optical density to the areas of the subunit peaks 
captured on Dynamax software 
Isolated 50S subunits were used to determine the relationship between the quantity of 
subunit particles and the area  under the curves obtained from Dynamax integration software 
and the results are shown in Figure 48. 
 
FIGURE 48.  50S RIBOSOMAL SUBUNIT QUANTITATION USING INTEGRATED 
AREA FROM SUCROSE GRADIENT PROFILES. 
 Isolated 50S subunits were quantitated by optical density and centrifuged on sucrose 
gradients using the same method described for cell lysates.  Gradient profiles were captured 
using Dynamax  integration software and the areas of the 50S peaks were recorded. 
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The relationship between the Dynamax integrated area and 50S subunits (OD) was 
determined to be:  area = 8,214,013(OD) + 19,601.  This equation allowed a determination of 
the amount of 50S subunits present in sucrose gradients using the captured Dynamax profiles.  
One optical density unit of 50S subunits at 260 nm =  44 pmol/ml.  Figure 49 shows the results 
of filter binding assays testing the in vitro binding of erythromycin to isolated 50S subunits. 
 
FIGURE 49.  IN VITRO BINDING OF 14C-ERYTHROMYCIN  TO ISOLATED 50S 
SUBUNITS. 
 Different amounts of 50S subunits were incubated at 37oC for 20 minutes with 0.1 mCi 
of 14C-erythromycin.  The 50S subunits in each sample were captured on GF/A filters, rinsed 
with 3 ml of S-buffer and the CPM of bound 14C-erythromycin was determined by liquid 
scintillation counting. 
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Filter binding assays using 14C-erythromycin were performed on isolated ribosomal 
subunit samples.  They showed a stoichiometric 1:1 binding ratio between erythromycin and 
50S subunit molecules.  No binding above background levels was seen between erythromycin 
and 30S subunits (data not shown). 
To test precursor binding stoichiometry in vitro, strain SK901 was grown in T broth at 
37oC, with and without unlabeled erythromycin.   Strain SK5665 was examined similarly  but 
using 18 mg/ml of erythromycin.  Sucrose gradient fractions corresponding to the 30S-40S and 
the 50S peaks were pooled, dialyzed and incubated with 14C-erythromycin  as described.  
Filter binding assays were used to determine the amount of isotope that bound to each gradient 
pool and the results are shown in Table 11.  Precursor particles recovered from erythromycin 
inhibited cells bound as much erythromycin as 50S subunits, showing a similar 1:1 binding 
stoichiometry. 
 
Table 11.  In vitro Erythromycin Binding to Pooled Gradient Fractions.  
 
 
  Pooled  Cells grown Recovered Bound  RNA/ 
Gradient in unlabeled pmol  pmol   ERY 
Strain  Peak  [ERY]  rRNA  14C ERY Ratio 
SK901  30S-40S  None  9.9  0.5  0.05 
SK901  50S  None  8.8  6.5  0.74 
SK901  30S-40S 18 mg/ml 7.9-13.7 4.0  0.3-0.5 
SK901  50S  18 mg/ml 5.7  3.5  0.61 
 
SK5665 30S-40S None  12.2  0.6  0.05 
SK5665 50S  None  9.7  6.2  0.64 
SK5665 30S-40S 18 mg/ml 8.8-15.2 5.1  0.3-0.6 
SK5665 50S  18 mg/ml 4.8  3.0  0.63 
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Cells grown without antibiotic yielded 30S-40S pools that did not bind as much 14C-
erythromycin  in vitro as the 50S pools did.  When cells were grown in the presence of 
unlabeled erythromycin, both the 30S-40S and the 50S pools contained molecules that bound 
to 14C-erythromycin  in in vitro experiments.  
 The exact amount of pmoles of rRNA in the 30S-40S gradient region could not be 
determined because our data has shown this area to contain both 30S and precursor 50S 
subunits.  One optical density unit of 30S subunits at 260 nm =  76 pmol/ml and one optical 
density unit of 50S subunits at 260 nm =  44 pmol/ml,  so a range of values is given.  However, 
excess binding of 14C-erythromycin to 30S gradient pools was observed in the samples that had 
been grown in the presence of erythromycin compared to the 30S gradient pools from cells 
grown without antibiotic. 
  
 
Reconstitution of Ribosomal Subunits 
 
 An attempt was made to examine the effect of antibiotics on ribosomal subunit 
formation in vitro, using the method of subunit reconstitution.  Normal 30S and 50S particles 
were formed under standard reconstitution conditions. 
 Additionally, predicted reconstitution intermediate particles were isolated from 30S and 
50S reconstitution reactions when the reaction was kept at 0oC.  The in vitro reconstitution of 
30S subunits was not inhibited by the presence of any of the antibiotics tested. 
 The in vitro reconstitution using 50S subunits showed no inhibition in the presence of 
erythromycin or of three other macrolide antibiotics tested (see Figure 50).  This is in contrast to 
the demonstrated in vivo assembly effect of these antibiotics on 50S subunits.    
A number of antibiotics were tested for effects on both 30S and 50S subunit 
reconstitution.  The data are shown in Tables 12 and 13. 
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FIGURE 50.  RECONSTITUTION OF 50S RIBOSOMAL SUBUNITS. 
Total rRNA and 50S subunit proteins from MRE600 were used to reconstitute 50S 
subunits in vitro.  Reconstitutions done with no antibiotic (A) or with erythromycin at a 10 fold 
molar excess over the amount of rRNA (B) yielded similar results when analyzed by sucrose 
gradient sedimentation and compared to standards (C).  
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Table 12.  Antibiotics Used in 30S Subunit Reconstitutions. 
Reconstitutions were done in the presence of the antibiotics listed by adding rRNA, 
antibiotic, and then proteins to each reaction.  Inhibition of assembly of the 30S subunit was not 
observed under these reconstitution conditions. 
 
 
 
   Subunit Normally   Molar Ratio Effect on 30S 
Antibiotic  Affected in Translation  Drug/RNA Reconstitution 
 
Erythromycin   50S   1X  None 
Chloramphenicol  50S   1X  None 
Lincomycin   50S   1X  None 
Puromycin   50S   1X  None 
Spiramycin   50S   1X  None 
Thiostrepton   50S   1X  None 
Geneticin   30S   1X  None 
Gentamycin A   30S   1X  None 
Hygromycin B   30S   1X  None 
Canamycin Sulfate  30S   1X  None 
Neamine   30S   1X  None 
Neomycin   30S   1X  None 
Spectinomycin   30S   1X  None 
Streptomycin   30S   1X  None 
Tetracycline   30S   1X  None 
Tobramycin   30S   1X  None 
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Table 13.  Antibiotics Used in 50S Subunit Reconstitutions. 
Reconstitutions were done in the presence of the antibiotics listed by adding rRNA, 
antibiotic, and then proteins to each reaction.  In addition, erythromycin was tested  by adding 
the antibiotic to the reaction first and also by incubating the rRNA with the antibiotic at 37oC for 
15 minutes prior to adding the proteins.  Inhibition of assembly of either ribosomal subunit was 
not observed under these reconstitution conditions. 
 
 
        
   Subunit Normally   Molar Ratio Effect on 50S 
Antibiotic  Affected in Translation  Drug/rRNA Reconstitution 
Erythromycin   50S   1X  None 
Azithromycin   50S   1X  None 
Clarithromycin   50S   1X  None 
Oleandomycin   50S   1X  None 
Erythromycin   50S   10X  None 
Azithromycin   50S   10X  None 
Clarithromycin   50S   10X  None 
Oleandomycin   50S   10X  None 
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CHAPTER 4 
DISCUSSION 
 
 This inquiry into the nature of the effects of erythromycin and related macrolides on E. 
coli  cells has lead to the identification and partial characterization of the 50S ribosomal subunit 
intermediate particle that accumulates as a result of assembly inhibition of the 50S subunit by 
erythromycin. 
 
 
Prior Studies 
 
 Erythromycin and related antibiotics have been shown to inhibit 50S subunit function in 
translation and its mechanism has been well investigated (Corcoran 1984), with regard to the 
erythromycin binding site and mechanism of action.  Much less is known about macrolide effects 
on 50S subunit assembly.  Macrolide antibiotics have been shown to inhibit 50S subunit 
assembly in E. coli  (Chittum and Champney 1995), S. aureus and B. subtilis (Champney and 
Burdine 1998) cells.   
Recent studies (Champney 1999) have compared the effects of macrolides on the 
growth of E. coli  and S. aureus cells.  Azithromycin was a potent inhibitor of 50S assembly in 
both cell types at low concentrations.  Lower erythromycin concentrations were needed to 
inhibit 50S assembly in S. aureus than in E. coli .  Oleandomycin, the least effective of these 
antibiotics, caused only a small amount of 50S assembly inhibition in S. aureus and almost none 
in E. coli  when used at high concentrations.  With the exception of erythromycin being more 
effective against S. aureus, these data on E. coli  are consistent with our results from assays on 
growth and in vivo protein synthesis.  Another macrolide, clarithromycin, was found to be more 
effective than erythromycin at inhibiting 50S subunit assembly and had a greater effect on E. coli  
than S. aureus cells.   
 Structural differences among these antibiotics are the most likely reason for their 
differences in effects on growing cells (see Figure 6).  Oleandomycin is a naturally occurring 
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derivative of erythromycin, possessing a similar 14-membered macrolactone ring, but with an 
epoxy group at C8 instead of the methyl group (Nakagawa and Omura, 1984).  Azithromycin 
has a semi-synthetic 15-membered ring in which a ketone group has been replaced by a 
methylated nitrogen.  This modification reduces the susceptibility of the azithromycin ring to acid 
hydrolysis (Kirst and Sides 1989; Kirst 1993).  Another acid stable macrolide, clarithromycin, 
is a 6 methoxy derivative of erythromycin (Whitman and Tunkel 1992).  
 Studies on the relationship between the structure and function of several macrolide and 
related ketolide antibiotics in S. aureus showed that the macrolides roxithromycin and 
clarithromycin inhibited protein synthesis to a greater extent than they inhibited 50S subunit 
assembly.  A derivative of clarithromycin (11,12-carbonate-3 deoxy-clarithromycin) was found 
to have the inverse effect, inhibiting 50S subunit assembly more than protein synthesis 
(Champney and Tober 1999).  Other macrolides with specific structure changes are currently 
being examined to more precisely define the features responsible for their activities.  
 The ketolides are a second generation of macrolides in which the cladinose sugar at C3 
of the ring has been replaced by a ketone group (Nakagawa and Omura 1984).  Eleven of 
these compounds were found to be potent inhibitors of growth and 50S subunit assembly, even 
in an ermC erythromycin-resistant strain of S. aureus, suggesting that the ketolides are not 
inducers of the methylase gene expression (Champney and Tober 1998). 
 Recently, assembly inhibition of the 50S subunit has been reported in S. aureus cells by 
16-membered macrolides, lincomycin and clindamycin, streptogramin B (but not streptogramin 
A), as well as by a polysaccharide antibiotic evernimicin (Champney and Tober 2000 A; 
Champney and Tober 2000 B). 
 
 
Recovery from Erythromycin Effects 
 
 Recovery from the growth inhibiting effects of erythromycin varied between the strains 
tested.  The RNase E- mutant SK5665 took 45 minutes to resume logarithmic growth after 
removal of the antibiotic, compared to 30 minutes required by the wild type. This suggests that 
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RNase E mediated rRNA turnover may be important in overcoming macrolide effects.  The 
RNase 1- mutant MRE600 required 2 hours to resume logarithmic growth.  This was surprising, 
because RNase 1 is not recognized as an enzyme involved in the mediation of ribosomal 
assembly or turnover (Altman et al 1982).  Erythromycin hypersensitivity in MRE600 might 
either be due to stronger antibiotic binding to the ribosomes in this strain, or due to differences in 
erythromycin uptake or loss rates. 
 The temperature sensitive L15 mutants SK1217 and SK1219 did not resume any 
measurable growth after the removal of the antibiotic.  This may reflect either a tight binding of 
the drug to the ribosome or an unknown activity of the antibiotic that rendered these mutant 
ribosomes non-functional.  Although the nature of the L15 gene to L15 protein mutation in these 
strains has not been well characterized (Champney 1979).  L15 is an important erythromycin 
binding protein in 50S subunits (Teraoka and Nierhaus 1978). 
 
 
Uptake and Efflux of Erythromycin 
 
Entry of the antibiotic into cells is a prerequisite for directly affecting ribosomes.  
(Farmer, Li, and Hancock 1992).  In the antibiotic uptake experiments using 14C-erythromycin  
in growing cells, it was anticipated that uptake would be gradual.  Instead, the first sample taken 
at time zero immediately after addition of the isotope contained the highest amount of 
radioactivity.  After about five minutes, an equilibrium was reached and the amount of isotope in 
subsequent samples stabilized.  One explanation for these observations is that the erythromycin 
entered the cells rapidly and then began to be actively transported out of them.  
Further evidence for the rapid uptake of erythromycin in static cells was obtained both 
by increasing the amount of unlabeled antibiotic and by adding the unlabeled erythromycin 5 
seconds after the isotope.  In each instance, the uptake of isotope was slowed.  
 The erythromycin loss experiments showed a pattern similar to the uptake experiments.  
Cells grown in labeled erythromycin lost half the isotope within 5 minutes of resuspension in 
fresh T broth.  By about 15 minutes, the counts had stabilized and this may represent 
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erythromycin that was bound to ribosomes and not available as a substrate for export.  Strain 
MRE600 was hypersensitive to erythromycin and would not grow in T broth at antibiotic 
concentrations above 10 mg/ml.  This may be related to its reduced capacity for efflux of the 
antibiotic compared to the other strains.  Because of incomplete characterization of the 
mutations in strains MRE600, SK1217, and SK1219, strains SK901 and SK5665 were 
selected for further study and analysis. 
 
 
Pulse-Chase Analysis 
 
 Previous work in our lab had suggested that accumulation and turnover of  stalled 50S 
subunit precursor particles occurred in erythromycin-treated cells (for a review, see Champney 
1999).  These investigations used a pulse-chase labeling method to study the kinetic processes 
of ribosomal subunit assembly. 
 In order to determine whether stalled 50S assembly intermediates or fragments of 
degraded 50S subunits accumulated in erythromycin treated cells, pulse-chase assays were 
performed.  The pulse-chase assays revealed decreased rates of assembly of 50S subunits in 
both strains tested as well as varying levels of accumulation of a stalled 50S precursor assembly 
intermediate in the 30S gradient region of erythromycin-treated cells.  Dynamic analysis of the 
pulse-chase assays over time indicated that the stalled 50S precursor accumulated to a greater 
degree in the RNase E- mutant SK5665 than in the wild type SK901.  Reduction of the growth 
temperature from 37oC to 27oC resulted in slowed ribosomal subunit assembly in both strains 
and resulted in an increase in 50S precursor relative to the amount of fully formed 50S subunits 
that were assembled during the chase period. 
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RNA Analysis 
 
  To further characterize the 50S precursor particle(s), gradient fractions were assessed 
for both rRNA and protein content.  Fluorograms from gel electrophoresis of  rRNA from cells 
grown with erythromycin revealed 23S and 5S rRNA species within the 30S gradient region.  
Attempts to quantitate the precursor particle based on the amount of 23S rRNA were impeded 
by RNA breakdown during cell lysis and during handling of the samples.  Cleavage of the 23S 
rRNA at a sensitive site near its center often results in a pair of nucleotides that migrate on gels 
along with the 16S rRNA (Winkler 1979).   Gel electrophoresis and fluorography of cells 
grown with 3H uridine showed that top fractions from antibiotic treated cells contained much 
more RNA than did the non- antibiotic treated cultures. This RNA was not present as intact 
23S rRNA, but as smaller oligonucleotides. Champney and Burdine (1996) found that the 
inhibition of 50S subunit assembly was directly proportional to accumulation of 
oligoribonucleotides in erythromycin treated S. aureus cells.  
Slot blot hybridization experiments confirmed that the both the top fractions and 
fractions from the 30S gradient region contained more 23S rRNA than did those same fractions 
from cells grown without antibiotics.  Previous experiments (Champney and Burdine 1998) in S. 
aureus cells had revealed a direct relationship between loss of rRNA from 50S subunits and its 
accumulation as oligoribonucleotides in macrolide-treated cells. 
Fractions at the top of the sucrose gradients did not contain appreciable amounts of free 
ribosomal proteins.  This is not surprising, because ribosomal protein synthesis is highly 
regulated and pools of free ribosomal proteins are not maintained in E. coli  (Gupta and Singh 
1972; Marvaldi et al. 1974).  Overexpression of ribosomal proteins has been shown to be 
highly toxic in these cells (Fallon et al. 1979).  
 Although the gradient positions of the 30S subunit and the 50S assembly intermediates 
overlapped, we were able to distinguish one from the other based on 23S rRNA hybridization, 
the presence of 5S rRNA and their unique protein compositions.  Hybridization of a 23S 
rRNA-specific probe to gradient fractions using a slot blot technique was a more specific 
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method for differentiating 23S rRNA in 50S precursor particles from that of 16S rRNA in 30S 
subunits. 
 
 
Role of RNase E 
 
Strain SK5665 has a mutant ribonuclease E enzyme that is inactivated at reduced or 
elevated temperatures (Kushner, et al. 1993).  RNase E processes 9S pre-rRNA into mature 
5S rRNA and controls the degradation of  E. coli  mRNAs.  In these cells, RNase E is part of a 
multi-component complex called the degradosome that includes polynucleotide phosphorylase 
along with several other enzymes (Miczak et al. 1996; Coburn and Mackie 1998).  When RNA 
oligonucleotides from the degradosome were examined (Bessarab et al. 1998), they were found 
to be primarily fragments of 16S and 23S rRNA.  This indicates that the RNase E-containing 
degradosome mediates the turnover of mature rRNAs as well as mRNAs.   
At 27oC, strain SK5665 accumulated nearly twice as much 50S precursor than at 
37oC.  This accumulation may be due to the inactivation of the temperature-sensitive 
ribonuclease E.  The loss of this endonuclease may impair the normal degradation and turnover 
of the stalled 50S assembly intermediates.   
 
 
Protein Analysis 
 
 Analysis of the protein compositions of the 50S assembly intermediates was done to 
determine whether the particle that serves as a substrate for erythromycin might be similar to 
p150S, p250S, or RI50(1) 50S precursors that have been described (Nierhaus, et al 1973; 
Dohme and Nierhaus 1976).  Each of these particles contain 23S and 5S rRNAs but their 
protein compositions are different (see Table 7). 
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  Our results for the presence of early assembly proteins are consistent with the particles 
previously described except for the absence of L3 in SK901 and the presence of L6 in 
SK5665.  The protein L2 may have been present, but the spot believed to be L2 was 
misidentified in our gels.   More proteins were found in the SK5665 precursor than the one 
from SK901.  The SK5665 50S precursor tended to sediment into the 25S-30S gradient 
region whereas the SK901 50S precursor was more often found in the 30S-40S region.  
Because the higher molecular weight SK5665 particle was less dense, it may reflect an 
abnormal conformation of the assembling subunit.  The 50S assembly intermediate may have 
been more stable in the absence of RNase E. 
 Photoaffinity labeling experiments have been performed (Tejedor and Ballesta 1985) to 
identify the proteins associated with the erythromycin binding site of the 50S subunit.  Labeled 
photoreactive erythromycin was bound to intact 50S subunits and proteins L2, L27, and L28 
covalently bound to the antibiotic upon irradiation with UV light.  The presence of protein L2 
was not determined in our experiments.  Protein L27 was not found in the 50S precursor 
particle in either strain SK901 or SK5665 but was reported in both the p150S and p250S in 
vivo precursors.  Protein L28 was not present in any of the in vivo 50S assembly particles, 
including the ones isolated from cells grown with erythromycin. L28 was present, however, in 
the RI50(1) in vitro reconstitution intermediate.  
Additional photoaffinity labeling (Arevalo et al. 1988) found that L22 and L15 also 
reacted with the labeled erythromycin.  The location of these proteins on the subunit supports 
the model of erythromycin acting at the peptidyl transferase P site.  Protein L15 was found in 
the 50S intermediate assembly precursors of both SK901 and SK5665 strains grown in the 
presence of erythromycin.  Protein L15 was not present in the first in vivo assembly intermediate 
(p150S) but was found in the second in vivo assembly intermediate (p250S). 
   When Nierhaus and Teraoka (1978) tested isolated single ribosomal proteins for 
erythromycin binding ability, only L15 was able to bind the antibiotic.  Although L15 and L22 
were present in the assembly intermediates characterized in this work, L27 and L28 were not.  
These results suggest that the binding site for assembly inhibition may not contain the same 
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protein subset as does the binding site for translation inhibition in the fully formed 50S subunit.  
If the antibiotic binds L15 of the assembling subunit, it may sterically interfere with the addition 
of other proteins to that area (Franceschi and Nierhaus 1990).  Alternatively, erythromycin may 
bind to the assembling 50S subunit at a novel site that exists only transiently and its potential to 
bind there may be lost upon the addition of subsequent proteins. 
Erythromycin rapidly and non-covalently binds E. coli  50S ribosomal subunits with a 
1:1 stoichiometry (Tanaka and Teroka 1966;  Mao and Putterman 1969).  The binding is very 
stable (1.0 x 10-8M at 24oC) and it is specific for the 50S but not the 30S subunit.  The 
presence of 14C-erythromycin bound to particles that sedimented along with the 30S subunit is 
evidence that the cells contained appreciable amounts of incompletely or improperly assembled 
50S subunits.  The stoichiometry of erythromycin binding to the 50S subunit precursor was also 
found to be 1:1 (see Table 10).  Because of 23S rRNA deterioration problems, analysis of the 
5S rRNA was done and, labeled components of gradient fractions showed an approximate 1:1 
binding ratio between the 50S assembly intermediate  precursor and the antibiotic. 
Pulse-chase gradient analysis of strain SK901 using 14C-erythromycin  revealed 
increasing amounts of isotope binding over time to 50S subunits as well as to particles that were 
only dense enough to sediment near the 30S gradient region.  Strain SK5665 showed enhanced 
isotope binding over time in the same gradient fractions.   
Similar pulse-chase experiments using variable concentrations of  14C-erythromycin  
showed increased amounts of 50S precursor accumulation in the 30S region that bound 
increasing amounts of 14C-erythromycin.  However, these concentrations of erythromycin were 
not sufficient to produce differences in the amount of assembly of  normally sedimenting 50S 
subunits in SK901. 
 Strain SK5665 had large amounts of erythromycin-binding 50S precursor in the 30S 
region at all three antibiotic concentrations.  The assembly of fully-formed 50S subunits in 
SK5665 decreased dramatically as the antibiotic concentration increased.  These differences in 
subunit assembly likely are a reflection of the difference in erythromycin sensitivity between 
these strains, presumably related to the function of RNase E. 
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 In vitro analysis of erythromycin binding to particles recovered from sucrose gradients 
showed that after dialysis to remove the erythromycin,  particles from the 30S and 50S gradient 
regions were able to bind erythromycin by filter binding assay (Table 11). 
 
FIGURE 51.  MODEL OF  50S SUBUNIT ASSEMBLY INHIBITION BY 
ERYTHROMYCIN. 
No Drug  - Normal Assembly
+ Erythromycin
Assembly Intermediate
RNase
rRNA fragments
E
E
 
 
 
 
Based on the results from this work, we propose a model of the 50S assembly inhibition 
process as shown in Figure 51.  Assembly of the 50S subunit without the antibiotic present 
proceeds through two normal intermediate precursors that contain different protein subsets and 
both the 23S and 5S rRNAs (Nierhaus et al. 1973).  In the presence of erythromycin, a portion 
of the forming 50S subunits escape assembly inhibition and become normal 50S subunits.  
These are then capable of binding to erythromycin and being affected in translation.  According 
to our model, a subset of the developing 50S subunits bind to erythromycin and fail to become 
fully formed.  These stalled assembly intermediates then become substrates for ribonucleases 
like RNase E which degrade the particle. 
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 Several of the results obtained from these investigations lend support to the hypothesis 
stated in the introduction.  The 23S and 5S rRNA species were found in the 50S assembly 
intermediate precursor particle (see Figure 37, Figure 38, and Table 10).  50S ribosomal 
proteins were found in the 50S precursor (see Figure 41 and Figure 42).  The 50S precursor 
bound to erythromycin with the same stoichiometry as fully formed 50S subunits (see Table 9, 
Table 10, and Table 11).  In addition, increased build up of the 50S precursor was seen in an 
RNase E mutant (see Figure 21, Figure 27, and Figure 29). 
The portion of the hypothesis which stated that the in vivo assembly inhibition effect 
would be observed in an in vitro reconstitution assay was refuted.  Reconstitution of ribosomal 
subunits in vitro was successful despite the presence of antibiotics.  Properly sedimenting 30S 
and 50S subunits were reconstituted from their nucleic acid and protein components using 
methods modified from Dohme and Nierhaus (1976) and Amils et al., (1979).  The 
reconstitution methods used different ionic conditions and temperatures than are required by 
cells for assembly of subunits.  In addition, in vivo assembly of ribosomal subunits begins before 
the rRNAs are completely processed by nucleases or are methylated.   
Future investigations should include the examination of 50S assembly inhibition in other 
organisms, particularly in potential pathogens such as Staphylococcus and Streptococcus 
strains.  Isolation and characterization of mutant strains that are either resistant or hypersensitive 
to the 50S assembly inhibition effects of the macrolides will also prove useful in elucidating the 
molecular processes involved.  In addition, examination of the erythromycin binding affinity and 
kinetics of the intermediate precursor particle will prove insightful.  Techniques such as 
isothermal titration calorimitry can provide rapid and accurate binding assays requiring only 
minute amounts of the labile and difficult to isolate precursor particles. 
This research involved characterization of a process that has applications for 
development of more effective antimicrobial compounds.  Understanding the biochemical 
interactions responsible for antibiotic actions is an important prerequisite to deciding which 
modifications in antibiotic structure might enhance their activities.  Further research is needed to 
characterize the nature of the structure-function relationships responsible for antibiotic activity.  
The information obtained may lead to the development of a new arsenal of rationally designed 
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antibiotics, ones capable of meeting the challenge of emerging antibiotic resistance.  In contrast 
to the bacteriostatic effect of inhibiting protein synthesis, an antibiotic that binds preferentially to 
the 50S precursor could prove to be a highly bactericidal compound effectively halting assembly 
of ribosomes in the targeted cells.   
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